| La Roche-Posay | 91.7 | 3 | 4 |
| Cosmopolitan | 60.0 | 4 | 0 |
| Aveeno | 58.2 | 2 | 1 |
| Carl T. Hayden Veterans Affairs Medical Center | 51.7 | 3 | 0 |
| Aesop | 43.1 | 1 | 1 |
| Cetaphil | 43.1 | 1 | 1 |
| CeraVe | 43.1 | 1 | 1 |
| Dr. Jart+ | 43.1 | 1 | 1 |
| The Ordinary | 43.1 | 1 | 1 |
| Today | 41.0 | 2 | 0 |
| Glamour | 41.0 | 2 | 0 |
| United States Department of Veterans Affairs | 41.0 | 2 | 0 |
| Marie Claire | 41.0 | 2 | 0 |
| Neutrogena | 41.0 | 2 | 0 |
| Weekend Today | 41.0 | 2 | 0 |
| VA Ann Arbor Healthcare System | 41.0 | 2 | 0 |
| Megyn Kelly Today | 41.0 | 2 | 0 |
| cleanser | 34.5 | 0 | 3 |
| American journal of contact dermatitis : official journal of the American Contact Dermatitis Society | 34.5 | 0 | 3 |
| Sunscreen and facial skin care products in frontal fibrosing alopecia: a case control study | 34.5 | 0 | 3 |
| Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser | 34.5 | 0 | 3 |
| Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50 | 34.5 | 0 | 3 |
| To Investigate the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleanser in Healthy Females With Sensitive Skin | 34.5 | 0 | 3 |
| Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test | 34.5 | 0 | 3 |
| irritant dermatitis | 27.3 | 0 | 2 |
| No7 product line | 27.3 | 0 | 2 |
| Allergic contact dermatitis to synthetic rubber gloves: changing trends in patch test reactions to accelerators | 27.3 | 0 | 2 |
| Chemical assessment of "In-Use" allergic contact dermatitis patch test reagents from dermatology clinics | 27.3 | 0 | 2 |
| A review of perineal skin care protocols and skin barrier product use | 27.3 | 0 | 2 |
| Patch test reactions associated with sunscreen products and the importance of testing to an expanded series: retrospective analysis of North American Contact Dermatitis Group data, 2001 to 2010. | 27.3 | 0 | 2 |
| Positive patch test reactions to carba mix and iodopropynyl butylcarbamate: data from the North American Contact Dermatitis Group, 1998-2008. | 27.3 | 0 | 2 |
| Occupational contact dermatitis in hairdressers: an analysis of patch test data from the Danish contact dermatitis group, 2002-2011. | 27.3 | 0 | 2 |
| Clinical patch test data evaluated by multivariate analysis. Danish Contact Dermatitis Group | 27.3 | 0 | 2 |
| Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment | 27.3 | 0 | 2 |
| Allergic contact dermatitis from pharmaceutical grade BHA in Timodine, with no patch test reaction to analytical grade BHA. | 27.3 | 0 | 2 |
| Allergic patch test reactions associated with cosmetics: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2004. | 27.3 | 0 | 2 |
| Positive patch test reactions to lanolin: cross-sectional data from the north american contact dermatitis group, 1994 to 2006. | 27.3 | 0 | 2 |
| Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data. | 27.3 | 0 | 2 |
| A comparative study of allergic contact dermatitis by patch test versus reflectance confocal laser microscopy, with nickel and cobalt | 27.3 | 0 | 2 |
| Supplementation of flaxseed oil diminishes skin sensitivity and improves skin barrier function and condition | 27.3 | 0 | 2 |
| Common Allergens Identified Based on Patch Test Results in Patients with Suspected Contact Dermatitis of the Scalp. | 27.3 | 0 | 2 |
| Allergic contact dermatitis pattern in Kuwait: nickel leads the pack. In-depth analysis of nickel allergy based on the results from a large prospective patch test series report | 27.3 | 0 | 2 |
| Sensitive Skin: Assessment of the Skin Barrier Using Confocal Raman Microspectroscopy. | 27.3 | 0 | 2 |
| Effect of standardized skin care regimens on neonatal skin barrier function in different body areas | 27.3 | 0 | 2 |
| Occupational contact dermatitis in painters: an analysis of patch test data from the Danish Contact Dermatitis Group | 27.3 | 0 | 2 |
| Occupational allergic contact dermatitis and patch test results of leather workers at two Indonesian tanneries. | 27.3 | 0 | 2 |
| Allergic contact dermatitis to benzocaine: the importance of concomitant positive patch test results | 27.3 | 0 | 2 |
| Validity and ethics of the human 4-h patch test as an alternative method to assess acute skin irritation potential | 27.3 | 0 | 2 |
| Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care | 27.3 | 0 | 2 |
| Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis | 27.3 | 0 | 2 |
| Allergic contact dermatitis from ophthalmic products: can pre-treatment with sodium lauryl sulfate increase patch test sensitivity? | 27.3 | 0 | 2 |
| Efficacy of a barrier cream and its vehicle as protective measures against occupational irritant contact dermatitis | 27.3 | 0 | 2 |
| Skin Irritation to Glass Wool or Continuous Glass Filaments as Observed by a Patch Test among Human Japanese Volunteers | 27.3 | 0 | 2 |
| Toll-like receptor 3 activation is required for normal skin barrier repair following UV damage | 27.3 | 0 | 2 |
| Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate-induced irritation | 27.3 | 0 | 2 |
| Recommendation to increase the test concentration of methylchloroisothiazolinone/methylisothiazolinone in the European baseline patch test series - on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact De | 27.3 | 0 | 2 |
| Evaluation of the histologic characteristics of patch test confirmed allergic contact dermatitis | 27.3 | 0 | 2 |
| In vivo assessment of the effect of a cream containing Avena Rhealba® extract and hyaluronic acid on the restoration of the skin barrier in de-epidermised skin produced with an erbium-YAG laser | 27.3 | 0 | 2 |
| Analysis of skin patch test results and metalloproteinase-2 levels in a patient with contact dermatitis | 27.3 | 0 | 2 |
| Study of irritant contact dermatitis produced by repeat patch test with sodium lauryl sulfate and assessed by visual methods, transepidermal water loss, and laser Doppler velocimetry | 27.3 | 0 | 2 |
| Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair | 27.3 | 0 | 2 |
| Allergic contact dermatitis in 136 children patch tested between 2000 and 2006. | 27.3 | 0 | 2 |
| Patch test standard series recommended by the Brazilian Contact Dermatitis Study Group during the 2006-2011 period | 27.3 | 0 | 2 |
| Patch test results in patients with allergic contact dermatitis in the Podlasie region. | 27.3 | 0 | 2 |
| The effectiveness of a skin care program for the prevention of contact dermatitis in health care workers (the Healthy Hands Project): study protocol for a cluster randomized controlled trial | 27.3 | 0 | 2 |
| Add-on diagnostic tool for allergic contact dermatitis: the strip patch test. | 27.3 | 0 | 2 |
| Contact dermatitis to topical medicaments: a retrospective chart review from the Ottawa Hospital Patch Test Clinic | 27.3 | 0 | 2 |
| Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management | 27.3 | 0 | 2 |
| Recommendation to include methylisothiazolinone in the European baseline patch test series--on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group | 27.3 | 0 | 2 |
| Patch test results in 542 patients with suspected contact dermatitis in Turkey | 27.3 | 0 | 2 |
| Contact dermatitis after implantable cardiac defibrillator implantation for ventricular tachycardia | 27.3 | 0 | 2 |
| Occupational Contact Dermatitis: Workers' Compensation Patch Test Results of Portland, Oregon, 2005-2014. | 27.3 | 0 | 2 |
| Effects of a Skin Barrier Cream on Management of Incontinence-Associated Dermatitis in Older Women: A Cluster Randomized Controlled Trial | 27.3 | 0 | 2 |
| Efficacy and Tolerability of a Cosmetic Skin Care Product With Trans-4-t-butylcyclohexanol and Licochalcone A in Subjects With Sensitive Skin Prone to Redness and Rosacea | 27.3 | 0 | 2 |
| Survey of Occupational Allergic Contact Dermatitis and Patch Test among Clothing Employees in Beijing. | 27.3 | 0 | 2 |
| IN VIVO EVALUATION OF SKIN IRRITATION POTENTIAL, MELASMA AND SEBUM CONTENT FOLLOWING LONG TERM APPLICATION OF SKIN CARE CREAM IN HEALTHY ADULTS, USING NON-INVASIVE BIOMETROLOGICAL TECHNIQUES | 27.3 | 0 | 2 |
| The three moments of skin cream application: an evidence-based proposal for use of skin creams in the prevention of irritant contact dermatitis in the workplace | 27.3 | 0 | 2 |
| Skin Barrier Health: Regulation and Repair of the Stratum Corneum and the Role of Over-the-Counter Skin Care | 27.3 | 0 | 2 |
| The anti‐inflammatory effect of cherry blossom extract (Prunus yedoensis) used in soothing skincare product | 27.3 | 0 | 2 |
| Exogenous Factors in Skin Barrier Repair | 27.3 | 0 | 2 |
| Efficacy of a Hand Regimen in Skin Barrier Protection in Individuals With Occupational Irritant Contact Dermatitis | 27.3 | 0 | 2 |
| Non-sting barrier cream in radiotherapy-induced skin reactions | 27.3 | 0 | 2 |
| North American Contact Dermatitis Group Patch Test Results 2013-2014. | 27.3 | 0 | 2 |
| Case studies assessing a new skin barrier repair cream for the treatment of atopic dermatitis | 27.3 | 0 | 2 |
| Re "International survey on skin patch test procedures, attitudes and interpretation" L.K. Tanno et al., WAOJ (2016) 9:8. | 27.3 | 0 | 2 |
| Allergic contact dermatitis caused by efinaconazole: positive patch test reactions up to 0.1% pet. | 27.3 | 0 | 2 |
| The Spanish standard patch test series: 2016 update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC). | 27.3 | 0 | 2 |
| Patch test results of the European baseline series among patients with occupational contact dermatitis across Europe - analyses of the European Surveillance System on Contact Allergy network, 2002-2010. | 27.3 | 0 | 2 |
| North American contact dermatitis group patch test results: 2011-2012. | 27.3 | 0 | 2 |
| Evaluation of a skin barrier cream for managing IAD in elderly patients using high-frequency ultrasound | 27.3 | 0 | 2 |
| A Randomised Controlled Trial to evaluate the effect of a new skin care regimen on skin barrier function in those with podoconiosis in Ethiopia. | 27.3 | 0 | 2 |
| Allergic contact dermatitis from a cream containing Centella asiatica extract | 27.3 | 0 | 2 |
| Polysensitisation in a laboratory scientist associated with allergic contact dermatitis from methylisothiazolinone in skin cleansers | 27.3 | 0 | 2 |
| Patch Test Results from an Occupational and Contact Dermatitis Clinic in a Tertiary Care Hospital of Southern India: A Retrospective Study | 27.3 | 0 | 2 |
| Contact dermatitis due to Centella asiatica | 27.3 | 0 | 2 |
| Semipermeable glove membranes--effects on skin barrier repair following SLS irritation | 27.3 | 0 | 2 |
| Shoe contact dermatitis from dimethyl fumarate: clinical manifestations, patch test results, chemical analysis, and source of exposure. | 27.3 | 0 | 2 |
| Systemic allergic contact dermatitis due to phenylephrine in eyedrops, with a long-lasting allergic patch test reaction | 27.3 | 0 | 2 |
| Ambroxol-induced systemic contact dermatitis confirmed by positive patch test | 27.3 | 0 | 2 |
| Cumulative irritation patch test of sanitary pads on sensitive skin | 27.3 | 0 | 2 |
| Cumulative skin irritation test of sanitary pads in sensitive skin and normal skin population | 27.3 | 0 | 2 |
| Methylchloroisothiazolinone and Methylisothiazolinone Allergic Contact Dermatitis and the Effect of Patch Test Concentration | 27.3 | 0 | 2 |
| Sanitary napkin contact dermatitis of the vulva: location-dependent differences in skin surface conditions may play a role in negative patch test results | 27.3 | 0 | 2 |
| Reduced levels of glutathione S-transferases in patch test reactions to dithranol and sodium lauryl sulphate as demonstrated by quantitative immunocytochemistry: evidence for oxidative stress in acute irritant contact dermatitis | 27.3 | 0 | 2 |
| Patch test results with tixocortol pivalate and budesonide in Germany and Austria | 27.3 | 0 | 2 |
| Combination therapy improves the recovery of the skin barrier function: an experimental model using a contact allergy patch test combined with TEWL measurements | 27.3 | 0 | 2 |
| Late reactions to patch test preparations with reduced concentrations of p-phenylenediamine: a multicentre investigation of the German Contact Dermatitis Research Group | 27.3 | 0 | 2 |
| Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief? | 27.3 | 0 | 2 |
| A noninvasive method to assess skin irritation and compromised skin conditions using simple tape adsorption of molecular markers of inflammation | 27.3 | 0 | 2 |
| Short term study of human skin irritation by single application closed patch test: assessment of four multiple emulsion formulations loaded with botanical extracts. | 27.3 | 0 | 2 |
| Population differences in acute skin irritation responses. Race, sex, age, sensitive skin and repeat subject comparisons. | 27.3 | 0 | 2 |
| A paired, double-blind, randomized comparison of a moisturizing durable barrier cream to 10% glycerine cream in the prophylactic management of postmastectomy irradiation skin care: trans Tasman Radiation Oncology Group (TROG) 04.01. | 27.3 | 0 | 2 |
| The profile of patch test reactions to common contact allergens is related to sex. | 27.3 | 0 | 2 |
| Lyral has been included in the patch test standard series in Germany | 27.3 | 0 | 2 |
| P2X purinergic receptor antagonist accelerates skin barrier repair and prevents epidermal hyperplasia induced by skin barrier disruption | 27.3 | 0 | 2 |
| Common contact sensitizers in the Czech Republic. Patch test results in 12,058 patients with suspected contact dermatitis*. | 27.3 | 0 | 2 |
| Concomitant patch test reactions to mercapto mix and mercaptobenzothiazole: retrospective analysis from the North American Contact Dermatitis Group, 1994-2008. | 27.3 | 0 | 2 |
| Positive patch test reactions in older individuals: Retrospective analysis from the North American Contact Dermatitis Group, 1994-2008 | 27.3 | 0 | 2 |
| Histologic aspects of patch test reactions in allergic contact dermatitis | 27.3 | 0 | 2 |
| Panel discussion: skin cleansers | 27.3 | 0 | 2 |
| Electroporation and ultradeformable liposomes; human skin barrier repair by phospholipid | 27.3 | 0 | 2 |
| Allergic contact dermatitis due to phenylephrine hydrochloride, with an unusual patch test reaction | 27.3 | 0 | 2 |
| Comparison of patch test contact sensitivity to acetone and aqueous extracts of Parthenium hysterophorus in patients with airborne contact dermatitis | 27.3 | 0 | 2 |
| Effect of semipermeable membranes on skin barrier repair following tape stripping | 27.3 | 0 | 2 |
| Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group | 27.3 | 0 | 2 |
| Patch test results with the metalworking fluid series of the German Contact Dermatitis Research Group (DKG). | 27.3 | 0 | 2 |
| Valdecoxib-induced systemic contact dermatitis confirmed by positive patch test | 27.3 | 0 | 2 |
| Characteristics of patch test reactions to common preservatives incorporated in petrolatum and water, respectively | 27.3 | 0 | 2 |
| The American Academy of Dermatology patch test series for contact dermatitis | 27.3 | 0 | 2 |
| Pesticide patch test series for the assessment of allergic contact dermatitis among banana plantation workers in panama. | 27.3 | 0 | 2 |
| North American Contact Dermatitis Group patch test results for 2007-2008. | 27.3 | 0 | 2 |
| Skin care products can aggravate epidermal function: studies in a murine model suggest a pathogenic role in sensitive skin. | 27.3 | 0 | 2 |
| Scratch-patch test for the diagnosis of allergic contact dermatitis to aciclovir | 27.3 | 0 | 2 |
| The Association of Race/Ethnicity and Patch Test Results: North American Contact Dermatitis Group, 1998-2006. | 27.3 | 0 | 2 |
| Patch Test Reactions to Corticosteroids: Retrospective Analysis From the North American Contact Dermatitis Group 2007-2014. | 27.3 | 0 | 2 |
| Response to letter to the editor re. Hines J, Wilkinson SM, John SM, et al. The three moments of skin cream application: an evidence-based proposal for use of skin creams in the prevention of irritant contact dermatitis in the workplace | 27.3 | 0 | 2 |
| Neuroimmunomodulatory compound for sensitive skin care: in vitro and clinical assessment | 27.3 | 0 | 2 |
| Comparative assessment of the acute skin irritation potential of detergent formulations using a novel human 4-h patch test method. | 27.3 | 0 | 2 |
| Addendum to Geier J, Lessmann H, Uter W, Schnuch A. Are concomitant patch test reactions to epoxy resin and BIS-GMA indicative of cross reactivity? Contact Dermatitis 2007: 57: 376-380. | 27.3 | 0 | 2 |
| Patch test results from the Mayo Clinic Contact Dermatitis Group, 1998-2000. | 27.3 | 0 | 2 |
| Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. | 27.3 | 0 | 2 |
| Crude 4-methylcyclohexanemethanol (MCHM) did not cause skin irritation in humans in 48-h patch test. | 27.3 | 0 | 2 |
| Regarding 'Frontal fibrosing alopecia: possible association with leave-on facial skincare products and sunscreens; a questionnaire study'. | 27.3 | 0 | 2 |
| Quality of life in postmenopausal women: translation and validation of MSkinQOL questionnaire to measure the effect of a skincare product in USA | 27.3 | 0 | 2 |
| Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils | 27.3 | 0 | 2 |
| Contact Dermatitis Associated With Skin Cleansers: Retrospective Analysis of North American Contact Dermatitis Group Data 2000-2014. | 27.3 | 0 | 2 |
| Analysis of sensitive skin barrier function: basic indicators and sebum composition | 27.3 | 0 | 2 |
| Applying a vernix caseosa based formulation accelerates skin barrier repair by modulating lipid biosynthesis. | 27.3 | 0 | 2 |
| Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment | 27.3 | 0 | 2 |
| Risks of Allergic Contact Dermatitis Elicited by Nickel, Chromium, and Organic Sensitizers: Quantitative Models Based on Clinical Patch Test Data | 27.3 | 0 | 2 |
| Use of frozen poloxamer as a base for Itchy skin conditions, including irritant contact dermatitis | 27.3 | 0 | 2 |
| Atopy Associated With Positive Patch Test and Possible Allergic Contact Dermatitis | 27.3 | 0 | 2 |
| Examination of the skin barrier repair/wound healing process using a living skin equivalent (LSE) model and matrix-assisted laser desorption-ionization-mass spectrometry imaging (MALDI-MSI). | 27.3 | 0 | 2 |
| Allergic contact dermatitis caused by hydroxyacetophenone in a face cream | 27.3 | 0 | 2 |
| The purpuric patch test in patients with allergic contact dermatitis from azo dyes | 27.3 | 0 | 2 |
| Colloidal Oatmeal <em>(Avena Sativa)</em> Improves Skin Barrier Through Multi-Therapy Activity | 27.3 | 0 | 2 |
| Patch test results in schoolchildren. Results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG) | 27.3 | 0 | 2 |
| S1 guideline on occupational skin products: protective creams, skin cleansers, skin care products (ICD 10: L23, L24) – short version | 27.3 | 0 | 2 |
| More positive patch test reactions with larger test chambers? Results from a study group of the German Contact Dermatitis Research Group (DKG). | 27.3 | 0 | 2 |
| Pattern of patch test reactivity among patients with clinical diagnosis of contact dermatitis: a hospital-based study | 27.3 | 0 | 2 |
| Patch test reactions in children, adults and the elderly. A comparative study in patients with suspected allergic contact dermatitis | 27.3 | 0 | 2 |
| Epicutaneous patch test results in children and adults with allergic contact dermatitis in Karlovac county: a retrospective survey | 27.3 | 0 | 2 |
| Female wet workers and contact dermatitis: patch test results and sensitization in North-East Italy. | 27.3 | 0 | 2 |
| Thoughts on how to improve the quality of multicentre patch test studies | 27.3 | 0 | 2 |
| Clinical expression of nickel contact dermatitis primed by diagnostic patch test. | 27.3 | 0 | 2 |
| The study of human skin irritation of a novel herbal skin care product and ingredients by human single closed patch testing | 27.3 | 0 | 2 |
| Epicutaneous patch test results in patients with allergic contact dermatitis in Karlovac county--a retrospective survey. | 27.3 | 0 | 2 |
| Ceramide analogue 14S24 ((S)-2-tetracosanoylamino-3-hydroxypropionic acid tetradecyl ester) is effective in skin barrier repair in vitro. | 27.3 | 0 | 2 |
| Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair. | 27.3 | 0 | 2 |
| Symmetrical Intertriginous Skin Eruption in a Patient With Positive Patch Test to Metal: Systemic Contact Dermatitis or Lichen Planus Pigmentosus Inversus? | 27.3 | 0 | 2 |
| Clinical, biophysical and immunohistochemical analysis of skin reactions to acute skin barrier disruption - a comparative trial between participants with sensitive skin and those with nonsensitive skin. | 27.3 | 0 | 2 |
| Survey of Patch Test Business Models in the United States by the American Contact Dermatitis Society | 27.3 | 0 | 2 |
| Disrupted Skin Barrier is Associated with Burning Sensation after Topical Tacrolimus Application in Atopic Dermatitis | 27.3 | 0 | 2 |
| Prevention of Airborne Propolis-Induced Allergic Contact Dermatitis With Barrier Cream | 27.3 | 0 | 2 |
| The identification and classification of skin irritation hazard by a human patch test | 27.3 | 0 | 2 |
| The Influence of Two Different Foam Creams on Skin Barrier Repair of Foot Xerosis: A Prospective, Double-Blind, Randomised, Placebo-Controlled Intra-Individual Study | 27.3 | 0 | 2 |
| Tolerance of fragranced and fragrance-free facial cleansers in adults with clinically sensitive skin | 27.3 | 0 | 2 |
| Patch test reactions to the chinese standard screening allergens in 1,135 patients investigated for allergic contact dermatitis | 27.3 | 0 | 2 |
| Occupational contact dermatitis caused by methylchloroisothiazolinone/methylisothiazolinone through exposure to filler dust containing this preservative and with a positive patch test reaction to the dust. | 27.3 | 0 | 2 |
| Efficacy of the combined use of a facial cleanser and moisturizers for the care of mild acne patients with sensitive skin | 27.3 | 0 | 2 |
| The perceived obstacles in performing patch test to detect allergic contact dermatitis: a comparison between community allergists and directors of allergy training programs | 27.3 | 0 | 2 |
| Results of Hairdressing Series Patch Test in Patients with Allergic Contact Dermatitis to Para-phenylenediamine; Are there any Safe Alternatives? | 27.3 | 0 | 2 |
| Pilot study on a new concept of documenting the clinical relevance of patch test results in contact dermatitis patients | 27.3 | 0 | 2 |
| Statistical analysis plan for the Healthy Hands Project; single centre cluster-randomised clinical trial of a skin care program for the prevention of contact dermatitis in health care workers | 27.3 | 0 | 2 |
| Skin care in occupational contact dermatitis of the hands | 27.3 | 0 | 2 |
| Strip patch test vs. conventional patch test to detect type IV sensitization in patients with allergic contact dermatitis | 27.3 | 0 | 2 |
| Clinical Analysis of the Influence of Using the Skin Care Products on the Diaper Area in Comparison With Using a Cotton Wool Cloth, Moistened With Clear Water on the Skin Physiology of the Newborns From the 1st Day to the 4th Week of Life | 27.3 | 0 | 2 |
| Lactacyd Radiance (Lactic Acid) Prophetic Patch Test | 27.3 | 0 | 2 |
| Skin Biophysical Parameters and Patch Test Results in People Predisposing to Xiaotong Tiegao Induced Irritant Contact Dermatitis | 27.3 | 0 | 2 |
| Analysis of Epicutaneous Patch Test Results in Patients with Contact Dermatitis | 27.3 | 0 | 2 |
| Cumulative Skin Irritation Potential of a New 25 mg Nicotine Patch | 27.3 | 0 | 2 |
| Comparative Safety Study of New Sinecort Formulation Versus Positive Control | 27.3 | 0 | 2 |
| A 21-Day Study to Evaluate the Skin Irritation Potential of CCP-020 (Diacerein 1%) Topical Ointment in Healthy Subjects Using a Cumulative Irritant Patch Test Design | 27.3 | 0 | 2 |
| Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Dermacontrol Oil Control Moisturizer SPF 30 | 27.3 | 0 | 2 |
| Patch Test Skin Irritation/Sensitization of Cetaphil Daily Advance Ultra Hydration Lotion | 27.3 | 0 | 2 |
| Cumulative Skin Irritation Potential of a New 15 mg Nicotine Patch | 27.3 | 0 | 2 |
| Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream | 27.3 | 0 | 2 |
| Assessment of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure | 27.3 | 0 | 2 |
| Evaluation of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure | 27.3 | 0 | 2 |
| To Evaluate Skin Irritation and Skin Sensitisation of Developmental Cosmetic Facial Products | 27.3 | 0 | 2 |
| Patch Test Skin Irritation/Sensitization of Cetaphil Restoraderm Skin Restoring Body Wash | 27.3 | 0 | 2 |
| An RCT to Evaluate the Effect of a New Skin Care Regimen on SBF in Those With Podoconiosis | 27.3 | 0 | 2 |
| Skin Irritation Study of GSK2894512 Cream | 27.3 | 0 | 2 |
| Evaluation of contact dermatitis using the TRUE patch test | 27.3 | 0 | 2 |
| Skin and laboratory tests: comparison of the epicutaneous patch test with the TTL and LIF tests in the diagnosis of medicamentous allergic contact dermatitis | 27.3 | 0 | 2 |
| Histopathological changes in canine allergic contact dermatitis patch test reactions. A study on spontaneously hypersensitive dogs | 27.3 | 0 | 2 |
| Effects of topically applied glucocorticosteroids on patch test responses and recruitment of inflammatory cells in allergic contact dermatitis | 27.3 | 0 | 2 |
| PUVA treatment of nickel contact dermatitis: effect on dermatitis, patch test sensitivity, and lymphocyte transformation reactivity | 27.3 | 0 | 2 |
| Patch test of mercury compounds and disinfectant solutions and the clinical picture of mercury contact dermatitis | 27.3 | 0 | 2 |
| Validity of patch test screening trays in the evaluation of patients with allergic contact dermatitis | 27.3 | 0 | 2 |
| Result of patch test and allergic contact dermatitis--statistics over the past six years | 27.3 | 0 | 2 |
| Substances most frequently causing contact dermatitis and skin irritation in Poland. I. Cosmetics | 27.3 | 0 | 2 |
| An arm immersion model of compromised skin (II). Influence on minimal eliciting patch test concentrations of nickel | 27.3 | 0 | 2 |
| Contact hypersensitivity to corticosteroids in routine patch test patients. A multi-centre study of the Swiss Contact Dermatitis Research Group | 27.3 | 0 | 2 |
| Patch test results in hairdressers with contact dermatitis in Greece (1985-1994) | 27.3 | 0 | 2 |
| Utility objects most frequently causing contact dermatitis and skin irritation in Poland. V. Other products causing eczema | 27.3 | 0 | 2 |
| Allergic contact dermatitis from doxepin cream. One-year patch test clinic experience | 27.3 | 0 | 2 |
| A clinical and patch test study of contact dermatitis from traditional Chinese medicinal materials | 27.3 | 0 | 2 |
| Allergic contact dermatitis from butoxyethyl nicotinic acid and Centella asiatica extract | 27.3 | 0 | 2 |
| Contact dermatitis after calcipotriol and patch test evaluation | 27.3 | 0 | 2 |
| Allergic contact dermatitis due to Centella asiatica: a new case | 27.3 | 0 | 2 |
| An immunohistochemical study on mild skin irritation induced by a single application of a low-molarity sodium dodecyl sulfate solution: keys to the prevention of irritant contact dermatitis | 27.3 | 0 | 2 |
| Evaluation of a human patch test for the identification and classification of skin irritation potential | 27.3 | 0 | 2 |
| Contact dermatitis, patch test response, and pentoxifyline. What conclusions can be drawn at present? | 27.3 | 0 | 2 |
| The patch test in contact dermatitis | 27.3 | 0 | 2 |
| Patch test in contact dermatitis | 27.3 | 0 | 2 |
| Allergic contact dermatitis due to Centella asiatica extract | 27.3 | 0 | 2 |
| Histological distinction between early allergic and irritant patch test reactions: follicular spongiosis may be characteristic of early allergic contact dermatitis | 27.3 | 0 | 2 |
| Thoughts on sensitizers in a standard patch test series. The European Society of Contact Dermatitis | 27.3 | 0 | 2 |
| Interlaboratory evaluation of a human patch test for the identification of skin irritation potential/hazard | 27.3 | 0 | 2 |
| Patch test materials for mercury allergic contact dermatitis | 27.3 | 0 | 2 |
| Allergic contact dermatitis due to eye drops. Their clinical features and the patch test results | 27.3 | 0 | 2 |
| ROLE OF the patch test in contact dermatitis | 27.3 | 0 | 2 |
| lontophoretic Patch Test in Allergic Contact Dermatitis: 30 Years’ Experience | 27.3 | 0 | 2 |
| Application of a 4-h human patch test method for comparative and investigative assessment of skin irritation | 27.3 | 0 | 2 |
| North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens | 27.3 | 0 | 2 |
| Evaluation of skin barrier function in allergic contact dermatitis and atopic dermatitis using method of the continuous TEWL measurement | 27.3 | 0 | 2 |
| Dermal Cumulative Irritant Patch Study | 27.3 | 0 | 2 |
| Systemic contact dermatitis due to norfloxacin with a positive patch test to quinoline mix | 27.3 | 0 | 2 |
| Occupational allergic contact dermatitis in a patient with a positive patch test to tin | 27.3 | 0 | 2 |
| Associated positive patch test reactions to standard contact allergens | 27.3 | 0 | 2 |
| The effect of two moisturisers on skin barrier damage in allergic contact dermatitis | 27.3 | 0 | 2 |
| Allergic contact dermatitis from 5-fluorouracil with positive intradermal test and doubtful patch test reactions | 27.3 | 0 | 2 |
| Reproducibility of irritant patch test reactions to sodium lauryl sulfate in a double-blind placebo-controlled randomized study using clinical scoring. Results from a study group of the German Contact Dermatitis Research Group (Deutsche Kontaktaller | 27.3 | 0 | 2 |
| PHOTO-CONTACT DERMATITIS. THE PHOTO-PATCH TEST AS A VERIFICATION OF THE PHOTO-ALLERGIC NATURE | 27.3 | 0 | 2 |
| Compare the Skin Barrier Repair Function of Two Ceramide Containing Moisturizers | 27.3 | 0 | 2 |
| A high-positive patch test load correlates with further positive patch test reactions irrespective of their location | 27.3 | 0 | 2 |
| Standard patch test results in patients with contact dermatitis in Israel: age and sex differences | 27.3 | 0 | 2 |
| Dynamics of skin barrier repair following topical applications of miconazole nitrate | 27.3 | 0 | 2 |
| Positive patch test reactions to nickel sulphate are not modified by neighbouring negative fragrance patch tests. A multicenter-study by the German contact dermatitis research group | 27.3 | 0 | 2 |
| The effect of a daily facial cleanser for normal to oily skin on the skin barrier of subjects with acne | 27.3 | 0 | 2 |
| European Standard Series patch test results from a contact dermatitis clinic in Israel during the 7-year period from 1998 to 2004 | 27.3 | 0 | 2 |
| Determination of skin irritation potential in the human 4-h patch test | 27.3 | 0 | 2 |
| Case of allergic contact dermatitis due to a topical agent containing chlorpheniramine maleate, with a false-negative patch test | 27.3 | 0 | 2 |
| Positive patch test reaction without clinical contact dermatitis--what is the best approach in medico-legal evaluation? | 27.3 | 0 | 2 |
| Patch test in Chinese patients with cosmetic allergic contact dermatitis to common cosmetic allergens from a European cosmetic series | 27.3 | 0 | 2 |
| Are adverse skin reactions to cosmetics underestimated in the clinical assessment of contact dermatitis? A prospective study among 1075 patients attending Swedish patch test clinics | 27.3 | 0 | 2 |
| Two cases of contact dermatitis resulting from use of body wash as a skin moisturizer | 27.3 | 0 | 2 |
| Prevalence and 1-year outcome of facial allergic contact dermatitis in patients patch tested in a university hospital | 27.3 | 0 | 2 |
| Allergic contact dermatitis in 191 consecutively patch tested children | 27.3 | 0 | 2 |
| Allergic contact dermatitis and the endocannabinoid system: from mechanisms to skin care | 27.3 | 0 | 2 |
| Strong allergic patch test reactions may indicate a general disposition for contact allergy | 27.3 | 0 | 2 |
| Allergic contact dermatitis caused by sodium dehydroacetate, not hyaluronic acid, in Ialuset® cream | 27.3 | 0 | 2 |
| Dynamics of skin barrier repair following preconditioning by a biotechnology-driven extract from samphire (Crithmum maritimum) stem cells | 27.3 | 0 | 2 |
| Result of standard patch test in patients suspected of having allergic contact dermatitis | 27.3 | 0 | 2 |
| Irritation and allergy patch test analysis of topical treatments commonly used in wound care: Evaluation on normal and compromised skin | 27.3 | 0 | 2 |
| The patch test in contact dermatitis | 27.3 | 0 | 2 |
| The effect of Cetaphil Gentle Skin Cleanser on the skin barrier of patients with rosacea | 27.3 | 0 | 2 |
| Patch test results from a contact dermatitis clinic in North India | 27.3 | 0 | 2 |
| Role of the Patch Test in Contact Dermatitis | 27.3 | 0 | 2 |
| New treatments for restoring impaired epidermal barrier permeability: Skin barrier repair creams | 27.3 | 0 | 2 |
| Allergic contact dermatitis from heparin-containing gel: use of scratch patch test for diagnosis | 27.3 | 0 | 2 |
| A retrospective study of patients with facial allergic contact dermatitis patch tested with the European standard series in Turkey | 27.3 | 0 | 2 |
| Evaluation of an onion extract, Centella asiatica, and hyaluronic acid cream in the appearance of striae rubra | 27.3 | 0 | 2 |
| A rare case of allergic contact dermatitis from silver nitrate in a widely used special patch test marker | 27.3 | 0 | 2 |
| Irritant contact dermatitis. Part II. Evaluation evaluation of skin irritation potential of chemicals | 27.3 | 0 | 2 |
| The effect of damaged skin barrier induced by subclinical irritation on the sequential irritant contact dermatitis | 27.3 | 0 | 2 |
| Contact dermatitis caused by a footwear label with a positive patch test reaction to 2‐monomethylol phenol | 27.3 | 0 | 2 |
| Titanium dioxide induces eyelid dermatitis in patients allergic to gold | 27.3 | 0 | 2 |
| Understanding skin care and skin barrier function in infants | 27.3 | 0 | 2 |
| Non‐invasive assessment of tryptophan fluorescence and confocal microscopy provide information on skin barrier repair dynamics beyond TEWL | 27.3 | 0 | 2 |
| An ex vivo human skin model for studying skin barrier repair | 27.3 | 0 | 2 |
| Allergic patch test and contact dermatitis by in vivo reflectance confocal microscopy | 27.3 | 0 | 2 |
| Allergic contact dermatitis caused by undisclosed thiurams in a patch test tubular net | 27.3 | 0 | 2 |
| North American Contact Dermatitis Group patch test results: 2009 to 2010 | 27.3 | 0 | 2 |
| Canadian Consensus on Skin Barrier Repair Therapy in Atopic Dermatitis | 27.3 | 0 | 2 |
| Elevation of IL-9 in Extreme Patch Test Reactions Suggests It Is an Inflammatory Mediator in Allergic Contact Dermatitis | 27.3 | 0 | 2 |
| Occupational allergic contact dermatitis caused by coconut fatty acids diethanolamide | 27.3 | 0 | 2 |
| Limonene hydroperoxide analogues show specific patch test reactions | 27.3 | 0 | 2 |
| Patch test results of the dental personnel with contact dermatitis | 27.3 | 0 | 2 |
| Effects of washing of the face with a mild facial cleanser formulated with sodium laureth carboxylate and alkyl carboxylates on acne in Japanese adult males | 27.3 | 0 | 2 |
| The effects of benzylsulfonyl-D-Ser-homoPhe-(4-amidino-benzylamide), a dual plasmin and urokinase inhibitor, on facial skin barrier function in subjects with sensitive skin | 27.3 | 0 | 2 |
| Comments to: Hines J, Wilkinson SM, John SM, et al. The three moments of skin cream application: an evidence-based proposal for use of skin creams in the prevention of irritant contact dermatitis in the workplace. J Eur Acad Dermatol Venereol. 2016, | 27.3 | 0 | 2 |
| Food-Related Contact Dermatitis, Contact Urticaria, and Atopy Patch Test with Food | 27.3 | 0 | 2 |
| The role of skin barrier in occupational contact dermatitis | 27.3 | 0 | 2 |
| Pediatric Baseline Patch Test Series: Pediatric Contact Dermatitis Workgroup | 27.3 | 0 | 2 |
| Topical Hyaluronic Acid Facial Cream with New Micronized Molecule Technology Effectively Penetrates and Improves Facial Skin Quality: Results from In-vitro, Ex-vivo, and In-vivo (Open-label) Studies | 27.3 | 0 | 2 |
| Improving the Diagnosis of Allergic Contact Dermatitis Using Patch Test With Gloves | 27.3 | 0 | 2 |
| [Prediction of occupational allergic contact dermatitis induced by formaldehyde by IL17/IL22 secretion cell rest combined with patch test] | 27.3 | 0 | 2 |
| Compromising human skin in vivo and ex vivo to study skin barrier repair | 27.3 | 0 | 2 |
| Occupational contact dermatitis in Triveneto: Analysis of patch test data of the North Eastern Italian Database from 1996 to 2016 | 27.3 | 0 | 2 |
| Tertiary prevention of occupational skin diseases: Prevalence of allergic contact dermatitis and pattern of patch test results | 27.3 | 0 | 2 |
| Comparative assessment of 24-hr primary skin irritation test and human patch test data with in vitro skin irritation tests according to OECD Test Guideline 439 (for quasi-drugs in Japan) | 27.3 | 0 | 2 |
| Pumpkin seeds, Centella asiatica, Boswellia, Helichrysum, acetate vitamin E, Melaleuca alternifolia and hyaluronic acid phytocomplex monotherapy effects in patients with chronic pelvic pain syndrome | 27.3 | 0 | 2 |
| The effect of anti-IL-17 treatment on the reaction to a nickel patch test in patients with allergic contact dermatitis | 27.3 | 0 | 2 |
| Patch Test Practice Patterns of Members of the American Contact Dermatitis Society | 27.3 | 0 | 2 |
| Effectiveness of a skin care programme for the prevention of contact dermatitis in healthcare workers (the Healthy Hands Project): A single-centre, cluster randomized controlled trial | 27.3 | 0 | 2 |
| The Spectrum of Sensitive Skin: Considerations for Skin Care in Vulnerable Populations | 27.3 | 0 | 2 |
| Twenty-eight-day follow-up of patch test reactions to p-phenylenediamine and p-phenylenediamine dihydrochloride: A multicentre study on behalf of the European Environmental and Contact Dermatitis Research Group | 27.3 | 0 | 2 |
| Pigmented Facial Contact Dermatitis to Benzyl Salicylate: A Comparative Histopathological and Immunohistochemical Study of the Involved Skin and the Positive Patch Test Site | 27.3 | 0 | 2 |
| Clinicoepidemiological and Patch Test Profile of Patients Attending the Contact Dermatitis Clinic of a Tertiary Care Hospital in North India: A 7-Year Retrospective Study | 27.3 | 0 | 2 |
| A seven-year retrospective analysis of patch test data in a cohort of patients with contact dermatitis in Sri Lanka | 27.3 | 0 | 2 |
| Dermal targeting of Centella asiatica extract using hyaluronic acid surface modified niosomes | 27.3 | 0 | 2 |
| [Sensitive skin, reactive skin] | 27.3 | 0 | 2 |
| Comparison of transepidermal water loss rates in subjects with skin patch test positive vs negative to skin care products | 27.3 | 0 | 2 |
| [Function of Sacran as an Artificial Skin Barrier and the Development of Skincare Products] | 27.3 | 0 | 2 |
| Modulators of the endocannabinoid system influence skin barrier repair, epidermal proliferation, differentiation and inflammation in a mouse model | 27.3 | 0 | 2 |
| First case of contact dermatitis caused by C12-13 alkyl malate used in a skin care product for acne | 27.3 | 0 | 2 |
| Human T cell response to CD1a and contact dermatitis allergens in botanical extracts and commercial skin care products | 27.3 | 0 | 2 |
| Exploratory study to evaluate two clinical methods for assessing moisturizing effect on skin barrier repair | 27.3 | 0 | 2 |
| North American Contact Dermatitis Group Patch Test Results: 2015-2016 | 27.3 | 0 | 2 |
| Management of rosacea-prone skin: evaluation of a skincare product containing Ambophenol, Neurosensine, and La Roche-Posay Thermal spring water as monotherapy or adjunctive therapy | 27.3 | 0 | 2 |
| Practical approaches to skin barrier recovery and maintenance: principles of cleansing for children and adults | 27.3 | 0 | 2 |
| Skin irritation and sensitization of swine acellular dermal matrix treated with hyaluronic acid | 27.3 | 0 | 2 |
| Effects of Colloidal Oatmeal Topical Atopic Dermatitis Cream on Skin Microbiome and Skin Barrier Properties | 27.3 | 0 | 2 |
| Contact dermatitis caused by glucose sensors - 15 adult patients tested with a medical device patch test series | 27.3 | 0 | 2 |
| European Standard Series Patch Test Results in Contact Dermatitis Patients in a Tertiary Care Hospital | 27.3 | 0 | 2 |
| A Study to Assess the Local Cutaneous and Ocular Tolerance of Three Developmental Facial Skin-care Formulations. | 27.3 | 0 | 2 |
| Optical coherence tomography for patch test grading: a prospective study on its use for non-invasive diagnosis of allergic contact dermatitis | 27.3 | 0 | 2 |
| Continuous glucose monitoring systems give contact dermatitis in children and adults despite efforts of providing less "allergy- prone" devices Investigation and advice hampered by insufficient material for optimized patch test investigations | 27.3 | 0 | 2 |
| The Utility of an Occupational Contact Dermatitis Patch Test Database in the Analysis of Workplace Prevention Activities in Toronto, Canada | 27.3 | 0 | 2 |
| Role of Antimicrobial Peptides in Skin Barrier Repair in Individuals with Atopic Dermatitis | 27.3 | 0 | 2 |
| Currently Relevant P-Phenylenediamine Patch Test Reactions Associated with Hair Dye and Non-Scalp Anatomic Areas: Retrospective Cross-Sectional Analysis of North American Contact Dermatitis Group Data, 2001 to 2016 | 27.3 | 0 | 2 |
| Morphology-dependent titanium dioxide nanoparticle-induced keratinocyte toxicity and exacerbation of allergic contact dermatitis | 27.3 | 0 | 2 |
| Positive Patch Test Reactions to Carba Mix and Thiuram Mix: The North American Contact Dermatitis Group Experience (1994-2016) | 27.3 | 0 | 2 |
| Can We Separate Oral Lichen Planus from Allergic Contact Dermatitis and Should We Patch Test? A Systematic Review of Chronic Oral Lichenoid Lesions | 27.3 | 0 | 2 |
| A 96-hour Patch Test Study Using Healthy Human Volunteers to Assess the Skin Irritation Potential of 11 Topically Applied Formulations | 27.3 | 0 | 2 |
| Patch test informed consent form: position statement by European Academy of Dermatology and Venereology Task Force on Contact Dermatitis | 27.3 | 0 | 2 |
| 50 Human Subject Repeat Insult Patch Test | 27.3 | 0 | 2 |
| Study to Determine Skin Irritation and/or Sensitization Potential of an Antifungal Cream Containing Trolamine (Repeated Insult Patch Test) | 27.3 | 0 | 2 |
| Study to Determine Skin Irritation Potential of an Antifungal Cream Containing Trolamine After Repeated Skin Application (Cumulative Irritation Patch Test) | 27.3 | 0 | 2 |
| An Open-Label Clinical Study to Evaluate the Efficacy of a Face Cream and Eye Cream | 27.3 | 0 | 2 |
| Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic Dermatitis | 27.3 | 0 | 2 |
| Antagonistic Skin Toxicity of Co-Exposure to Physical Sunscreen Ingredients Zinc Oxide and Titanium Dioxide Nanoparticles | 27.3 | 0 | 2 |
| Evaluating the gentleness of a new professional model sonic skin care brush though non-invasive measurements of the skin barrier | 27.3 | 0 | 2 |
| WATER'S EDGE DERMATOLOGY | 27.3 | 0 | 2 |
| Compare the Skin Barrier Repair Function of Two Ceramide Containing Moisturizers | 27.3 | 0 | 2 |
| Patch Test Results in Patients with Suspected Contact Dermatitis at a Tertiary Care Hospital in a Semiurban Area in Rajasthan: A Cross-sectional Study | 27.3 | 0 | 2 |
| Etiology of Allergic Contact Dermatitis based on Patch Test | 27.3 | 0 | 2 |
| Patch Test Results in 169 Patients with Allergic Contact Dermatitis in Malatya | 27.3 | 0 | 2 |
| Allergic or Not: Final Interpretation of Doubtful Patch Test Reactions From the North American Contact Dermatitis Group, 2019–2020 | 27.3 | 0 | 2 |
| Promoting a Healthy Skin Barrier Using Skin Care in People With Mature Skin Xerosis | 27.3 | 0 | 2 |
| Hyaluronic Acid-Conjugated Thermoresponsive Polymer-Based Bioformulation Enhanced Wound Healing and Gut Barrier Repair of a TNBS-Induced Colitis Injury Ex Vivo Model in a Dynamic Perfusion Device | 27.3 | 0 | 2 |
| Influence of Brand Ambassador, Brand Awareness, and Price on Brand Image and Purchasing Decision in Halal Skincare Product (Study on MS Glow Skincare Products in Surabaya) | 27.3 | 0 | 2 |
| 712 Assessing skin barrier and stratum corneum surface integrity after application of skin cleansers on human skin by ex-vivo confocal laser scanning microscopy | 27.3 | 0 | 2 |
| 682 Induction of keratin 1 and keratin 10 expression by topical glucose in a mouse model of atopic dermatitis and in keratinocyte culture: A possible role of glucose in skin barrier repair | 27.3 | 0 | 2 |
| 674 TRPV1 positive peripheral sensory nerves are required for prompt skin barrier repair | 27.3 | 0 | 2 |
| Akita | 27.3 | 0 | 2 |
| DabiDabi | 27.3 | 0 | 2 |
| Q135293930 | 27.3 | 0 | 2 |
| Q137176402 | 27.3 | 0 | 2 |
| SENSITIVE SKIN, LLC | 27.3 | 0 | 2 |
| PowerV | 27.3 | 0 | 2 |
| Q79407 | 25.8 | 1 | 0 |
| Jenna Bush Hager | 25.8 | 1 | 0 |
| Harrods | 25.8 | 1 | 0 |
| La Roche-Posay | 25.8 | 1 | 0 |
| Macy's | 25.8 | 1 | 0 |
| Dove | 25.8 | 1 | 0 |
| Dateline NBC | 25.8 | 1 | 0 |
| Olay | 25.8 | 1 | 0 |
| Eucerin | 25.8 | 1 | 0 |
| Meet the Press | 25.8 | 1 | 0 |
| United States Secretary of Veterans Affairs | 25.8 | 1 | 0 |
| Vichy | 25.8 | 1 | 0 |
| Sephora | 25.8 | 1 | 0 |
| Clinique Laboratories, LLC | 25.8 | 1 | 0 |
| NBC News | 25.8 | 1 | 0 |
| Kiehl's | 25.8 | 1 | 0 |
| Prevention | 25.8 | 1 | 0 |
| Aveda | 25.8 | 1 | 0 |
| Bath VA Medical Center | 25.8 | 1 | 0 |
| Chapter 1607 | 25.8 | 1 | 0 |
| e.l.f. Cosmetics | 25.8 | 1 | 0 |
| Famous-Barr | 25.8 | 1 | 0 |
| Glamour Award | 25.8 | 1 | 0 |
| Hoda Kotb | 25.8 | 1 | 0 |
| Hooked: Muscle Women | 25.8 | 1 | 0 |
| Veterans Health Administration | 25.8 | 1 | 0 |
| Post-9/11 Veterans Educational Assistance Act of 2008 | 25.8 | 1 | 0 |
| SkinCeuticals | 25.8 | 1 | 0 |
| Tuskegee Veterans Administration Medical Center | 25.8 | 1 | 0 |
| Ulta Beauty | 25.8 | 1 | 0 |
| VA Boston Healthcare System | 25.8 | 1 | 0 |
| Yahoo! Shopping | 25.8 | 1 | 0 |
| Feel Good Food | 25.8 | 1 | 0 |
| Marion Veterans Affairs Medical Center | 25.8 | 1 | 0 |
| Bioderma | 25.8 | 1 | 0 |
| Who, What, Wear | 25.8 | 1 | 0 |
| Feel Good You | 25.8 | 1 | 0 |
| Healthline | 25.8 | 1 | 0 |
| Dermalogica Inc. | 25.8 | 1 | 0 |
| Woman & Home | 25.8 | 1 | 0 |
| Dermstore | 25.8 | 1 | 0 |
| NBC Out | 25.8 | 1 | 0 |
| Rodan + Fields | 25.8 | 1 | 0 |
| Birmingham VA Medical Center | 25.8 | 1 | 0 |
| Forefront of Dermatology | 25.8 | 1 | 0 |
| National Eczema Association | 25.8 | 1 | 0 |
| East Orange VA Medical Center | 25.8 | 1 | 0 |
| Omaha VA Medical Center | 25.8 | 1 | 0 |
| Nashville VA Medical Center | 25.8 | 1 | 0 |
| Jerry L. Pettis Memorial VA Medical Center | 25.8 | 1 | 0 |
| St. Louis VA Medical Center | 25.8 | 1 | 0 |
| National Rosacea Society | 25.8 | 1 | 0 |
| titanium dioxide | 17.2 | 0 | 1 |
| Clearasil | 17.2 | 0 | 1 |
| irritant diaper dermatitis | 17.2 | 0 | 1 |
| irritant contact dermatitis due to oils and greases | 17.2 | 0 | 1 |
| Centella asiatica | 17.2 | 0 | 1 |
| hyaluronic acid | 17.2 | 0 | 1 |
| triclosan | 17.2 | 0 | 1 |
| brookite | 17.2 | 0 | 1 |
| heartburn | 17.2 | 0 | 1 |
| photodermatitis | 17.2 | 0 | 1 |
| Flea allergy dermatitis | 17.2 | 0 | 1 |
| SQUID | 17.2 | 0 | 1 |
| miliaria | 17.2 | 0 | 1 |
| contact dermatitis | 17.2 | 0 | 1 |
| toner | 17.2 | 0 | 1 |
| personal lubricant | 17.2 | 0 | 1 |
| chromium allergic contact dermatitis | 17.2 | 0 | 1 |
| Akira Fujishima | 17.2 | 0 | 1 |
| skin care | 17.2 | 0 | 1 |
| patch test | 17.2 | 0 | 1 |
| Centella | 17.2 | 0 | 1 |
| cream | 17.2 | 0 | 1 |
| fine-tuned universe | 17.2 | 0 | 1 |
| Revlon | 17.2 | 0 | 1 |
| Patch test | 17.2 | 0 | 1 |
| barrier cream | 17.2 | 0 | 1 |
| occupational dermatitis | 17.2 | 0 | 1 |
| Biotherm | 17.2 | 0 | 1 |
| kangaroo care | 17.2 | 0 | 1 |
| Contact Dermatitis | 17.2 | 0 | 1 |
| Artistry | 17.2 | 0 | 1 |
| Hyaluronan sodium | 17.2 | 0 | 1 |
| Tiofine | 17.2 | 0 | 1 |
| burning sensation | 17.2 | 0 | 1 |
| NARS Cosmetics | 17.2 | 0 | 1 |
| Sensation | 17.2 | 0 | 1 |
| Missha | 17.2 | 0 | 1 |
| Airbag dermatitis | 17.2 | 0 | 1 |
| Alchimie Forever | 17.2 | 0 | 1 |
| Aquaphor | 17.2 | 0 | 1 |
| Bayankala | 17.2 | 0 | 1 |
| Bronner Bros. | 17.2 | 0 | 1 |
| Clarisonic | 17.2 | 0 | 1 |
| anti-aging cream | 17.2 | 0 | 1 |
| Ella Baché | 17.2 | 0 | 1 |
| EpiCeram | 17.2 | 0 | 1 |
| face cream | 17.2 | 0 | 1 |
| Esoterica | 17.2 | 0 | 1 |
| Freederm | 17.2 | 0 | 1 |
| Gold Bond | 17.2 | 0 | 1 |
| Kerala Minerals and Metals | 17.2 | 0 | 1 |
| Krebs Pigments and Chemical Company | 17.2 | 0 | 1 |
| local lymph node assay | 17.2 | 0 | 1 |
| Natural skin care | 17.2 | 0 | 1 |
| Noxzema | 17.2 | 0 | 1 |
| Protein contact dermatitis | 17.2 | 0 | 1 |
| Sensitive Skin | 17.2 | 0 | 1 |
| Sensitive Skin Magazine | 17.2 | 0 | 1 |
| Sensitive skin | 17.2 | 0 | 1 |
| Sensitive skin | 17.2 | 0 | 1 |
| Sensitive skin type | 17.2 | 0 | 1 |
| Category:Skin care | 17.2 | 0 | 1 |
| Simple Skincare | 17.2 | 0 | 1 |
| Skin cream | 17.2 | 0 | 1 |
| Tecnu | 17.2 | 0 | 1 |
| toxicodendron dermatitis | 17.2 | 0 | 1 |
| Category:Contact dermatitis | 17.2 | 0 | 1 |
| OXY | 17.2 | 0 | 1 |
| Hada Labo | 17.2 | 0 | 1 |
| Cidesco | 17.2 | 0 | 1 |
| viscosupplementation | 17.2 | 0 | 1 |
| allergic contact dermatitis | 17.2 | 0 | 1 |
| baby oil | 17.2 | 0 | 1 |
| Melem | 17.2 | 0 | 1 |
| cream | 17.2 | 0 | 1 |
| hyaluronic acid binding | 17.2 | 0 | 1 |
| glycosaminoglycan metabolic process | 17.2 | 0 | 1 |
| hyaluronan metabolic process | 17.2 | 0 | 1 |
| hyaluronan catabolic process | 17.2 | 0 | 1 |
| establishment of skin barrier | 17.2 | 0 | 1 |
| hyaluronan biosynthetic process | 17.2 | 0 | 1 |
| Pechoin | 17.2 | 0 | 1 |
| nickel allergic contact dermatitis | 17.2 | 0 | 1 |
| Hunan hand syndrome | 17.2 | 0 | 1 |
| Face Cream | 17.2 | 0 | 1 |
| KORA Organics | 17.2 | 0 | 1 |
| Premier Dead Sea | 17.2 | 0 | 1 |
| Nardo's Natural | 17.2 | 0 | 1 |
| Rachel K | 17.2 | 0 | 1 |
| Sensitive Skin | 17.2 | 0 | 1 |
| Q17478340 | 17.2 | 0 | 1 |
| Johnson's Baby | 17.2 | 0 | 1 |
| Habp4 | 17.2 | 0 | 1 |
| Habp2 | 17.2 | 0 | 1 |
| Gm7770 | 17.2 | 0 | 1 |
| Gm3318 | 17.2 | 0 | 1 |
| Ch. Surender Singh Memorial Herbal Park, Tosham | 17.2 | 0 | 1 |
| allergic contact dermatitis of eyelid | 17.2 | 0 | 1 |
| Pori titanium dioxide plant | 17.2 | 0 | 1 |
| contact dermatitis due to arnica | 17.2 | 0 | 1 |
| My Beauty Diary | 17.2 | 0 | 1 |
| Zoe Foster Blake | 17.2 | 0 | 1 |
| Skin care | 17.2 | 0 | 1 |
| Titanium dioxide nanoparticles increase sensitivity in the next generation of the water flea Daphnia magna | 17.2 | 0 | 1 |
| Hyaluronan binding protein 2 | 17.2 | 0 | 1 |
| epidermal lamellar body | 17.2 | 0 | 1 |
| Lymphatic vessel endothelial hyaluronan receptor 1 | 17.2 | 0 | 1 |
| Stabilin 2 | 17.2 | 0 | 1 |
| Hyaluronan synthase 1 | 17.2 | 0 | 1 |
| Hyaluronan synthase 2 | 17.2 | 0 | 1 |
| Hyaluronan mediated motility receptor | 17.2 | 0 | 1 |
| Titanium Dioxide (TiO2) Nanoparticles Preferentially Induce Cell Death in Transformed Cells in a Bak/Bax-Independent Fashion | 17.2 | 0 | 1 |
| Hyaluronan synthase 3 | 17.2 | 0 | 1 |
| titanium dioxide exposure | 17.2 | 0 | 1 |
| Contact dermatitis and other skin conditions in instrumental musicians | 17.2 | 0 | 1 |
| Alstonia scholaris R. Br. Significantly Inhibits Retinoid-Induced Skin Irritation In Vitro and In Vivo | 17.2 | 0 | 1 |
| Lymphatic vessel endothelial hyaluronan receptor 1 | 17.2 | 0 | 1 |
| Hyaluronic acid binding protein 2 | 17.2 | 0 | 1 |
| Hyaluronic acid binding protein 4 | 17.2 | 0 | 1 |
| Hydrocotyle asiatica | 17.2 | 0 | 1 |
| Hyaluronan mediated motility receptor (RHAMM) | 17.2 | 0 | 1 |
| Hyaluronan synthase 3 | 17.2 | 0 | 1 |
| Hyaluronan synthase 2 | 17.2 | 0 | 1 |
| Hyaluronan synthase 1 | 17.2 | 0 | 1 |
| Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators | 17.2 | 0 | 1 |
| Aveeno Baby product line | 17.2 | 0 | 1 |
| EOS Products, LLC | 17.2 | 0 | 1 |
| Industrial contact dermatitis: effect of the riot control agent ortho-chlorobenzylidene malononitrile | 17.2 | 0 | 1 |
| Induction of DNA double-strand breaks by asbestos, silica and titanium dioxide: do they provide an early predictive marker of carcinogenic potential? | 17.2 | 0 | 1 |
| Insights into the quantitative relationship between sensitization and challenge for allergic contact dermatitis reactions | 17.2 | 0 | 1 |
| Dissolution of cemented carbide powders in artificial sweat: implications for cobalt sensitization and contact dermatitis | 17.2 | 0 | 1 |
| Performance of a scanning mobility particle sizer in measuring diverse types of airborne nanoparticles: Multi-walled carbon nanotubes, welding fumes, and titanium dioxide spray | 17.2 | 0 | 1 |
| The public health impact of irritant contact dermatitis | 17.2 | 0 | 1 |
| Allergic contact dermatitis from triglycidyl isocyanurate in polyester paint pigments | 17.2 | 0 | 1 |
| Pulmonary inflammation after intraperitoneal administration of ultrafine titanium dioxide (TiO2) at rest or in lungs primed with lipopolysaccharide | 17.2 | 0 | 1 |
| Differential mouse pulmonary dose and time course responses to titanium dioxide nanospheres and nanobelts | 17.2 | 0 | 1 |
| Contact dermatitis from B. subtitliss-derived protease enzymes | 17.2 | 0 | 1 |
| Hyaluronic acid binding ability of human sperm reflects cellular maturity and fertilizing potential: selection of sperm for intracytoplasmic sperm injection | 17.2 | 0 | 1 |
| Pulmonary exposure of rats to ultrafine titanium dioxide enhances cardiac protein phosphorylation and substance P synthesis in nodose ganglia | 17.2 | 0 | 1 |
| The role of nodose ganglia in the regulation of cardiovascular function following pulmonary exposure to ultrafine titanium dioxide | 17.2 | 0 | 1 |
| Titanium dioxide nanoparticles: a review of current toxicological data | 17.2 | 0 | 1 |
| Occupational contact dermatitis in the UK: a surveillance report from EPIDERM and OPRA | 17.2 | 0 | 1 |
| A robust structure-activity relationship (SAR) model for esters that cause skin irritation in humans | 17.2 | 0 | 1 |
| Toxicological Evaluation of Lung Responses After Intratracheal Exposure to Non-Dispersed Titanium Dioxide Nanorods | 17.2 | 0 | 1 |
| Comparison of the biological activity between ultrafine and fine titanium dioxide particles in RAW 264.7 cells associated with oxidative stress | 17.2 | 0 | 1 |
| Titanium dioxide (TiO2) nanoparticles induce JB6 cell apoptosis through activation of the caspase-8/Bid and mitochondrial pathways | 17.2 | 0 | 1 |
| Comparison of inducible nitric oxide synthase gene expression and lung inflammation following intratracheal instillation of silica, coal, carbonyl iron, or titanium dioxide in rats | 17.2 | 0 | 1 |
| The pattern of tyrosine phosphorylation in human sperm in response to binding to zona pellucida or hyaluronic acid | 17.2 | 0 | 1 |
| Effects of Titanium Dioxide Nanoparticle Exposure on Neuroimmune Responses in Rat Airways | 17.2 | 0 | 1 |
| Exposure to titanium dioxide (TiO2) nanoparticles increases airway reactivity and neurogenic inflammation in rodent lungs | 17.2 | 0 | 1 |
| Acute stress modulates the irritant component of sensitizers in allergic contact dermatitis: implications for exposure assessment | 17.2 | 0 | 1 |
| Restraint-induced modulation of allergic and irritant contact dermatitis in male and female B6.129 mice | 17.2 | 0 | 1 |
| Concentrations and stability of methyl methacrylate, glutaraldehyde, formaldehyde and nickel sulfate in commercial patch test allergen preparations | 17.2 | 0 | 1 |
| Cellular interactions and biological responses to titanium dioxide nanoparticles in HepG2 and BEAS-2B cells: role of cell culture media | 17.2 | 0 | 1 |
| Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity | 17.2 | 0 | 1 |
| Synthesis, characterization, and bioactivity of carboxylic acid-functionalized titanium dioxide nanobelts | 17.2 | 0 | 1 |
| Thiurams in shoe contact dermatitis - a case series | 17.2 | 0 | 1 |
| Measuring surface area of airborne titanium dioxide powder agglomerates: relationships between gas adsorption, diffusion and mobility-based methods | 17.2 | 0 | 1 |
| Fate of airway epithelial cells exposed to titanium dioxide nanoparticles: NGF regulated apoptotic death | 17.2 | 0 | 1 |
| Titanium dioxide nanoparticles and diesel exhaust particles induced neuro-inflammatory modulation in human airway epithelial cells | 17.2 | 0 | 1 |
| Noninvasive evaluation of allergic and irritant contact dermatitis by in vivo reflectance confocal microscopy | 17.2 | 0 | 1 |
| Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area | 17.2 | 0 | 1 |
| Surface area of particle administered versus mass in determining the pulmonary toxicity of ultrafine and fine carbon black: comparison to ultrafine titanium dioxide | 17.2 | 0 | 1 |
| “Real-world” precision, bias, and between-laboratory variation for surface area measurement of a titanium dioxide nanomaterial in powder form | 17.2 | 0 | 1 |
| Pulmonary and cardiovascular responses of rats to inhalation of a commercial antimicrobial spray containing titanium dioxide nanoparticles | 17.2 | 0 | 1 |
| DNA double-strand breaks by asbestos, silica, and titanium dioxide | 17.2 | 0 | 1 |
| Irritant contact dermatitis among health care workers | 17.2 | 0 | 1 |
| Hyaluronic acid binding by human sperm indicates cellular maturity, viability, and unreacted acrosomal status. | 17.2 | 0 | 1 |
| Restraint stress applied prior to chemical sensitization modulates the development of allergic contact dermatitis differently than restraint prior to challenge | 17.2 | 0 | 1 |
| Contact dermatitis and workers' compensation: criteria for establishing occupational causation and aggravation | 17.2 | 0 | 1 |
| Chemical activation of innate and specific immunity in contact dermatitis | 17.2 | 0 | 1 |
| Confocal histopathology of irritant contact dermatitis in vivo and the impact of skin color (black vs white) | 17.2 | 0 | 1 |
| Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle | 17.2 | 0 | 1 |
| Hypoallergenic formula milk versus cow's milk for prevention of wheeze and asthma in children with a family history of atopy | 17.2 | 0 | 1 |
| Skin-to-skin care for procedural pain in neonates | 17.2 | 0 | 1 |
| Skin-to-skin care for procedural pain in neonates | 17.2 | 0 | 1 |
| Chlorhexidine skin care for the prevention of infection in term neonates | 17.2 | 0 | 1 |
| Hyaluronic Acid inclusion in embryo transfer media for assisted reproductive technologies | 17.2 | 0 | 1 |
| ROS generation is involved in titanium dioxide nanoparticle induced MAPKs/AP-1 activation in JB6 cells | 17.2 | 0 | 1 |
| Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease | 17.2 | 0 | 1 |
| Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing | 17.2 | 0 | 1 |
| Lipoxygenases mediate the effect of essential fatty acid in skin barrier formation: a proposed role in releasing omega-hydroxyceramide for construction of the corneocyte lipid envelope | 17.2 | 0 | 1 |
| TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation | 17.2 | 0 | 1 |
| Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2 | 17.2 | 0 | 1 |
| The expression of epidermal lipoxygenases and transglutaminase-1 is perturbed by NIPAL4 mutations: indications of a common metabolic pathway essential for skin barrier homeostasis | 17.2 | 0 | 1 |
| CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2 | 17.2 | 0 | 1 |
| Evaluation of the sensitization potential of two lubricant additives, phenyl-alpha-naphthylamine and alkylated phenyl-alpha-naph | 17.2 | 0 | 1 |
| Current intelligence bulletin 63: occupational exposure to titanium dioxide | 17.2 | 0 | 1 |
| Hyaluronic acid in human articular cartilage. Age-related changes in content and size | 17.2 | 0 | 1 |
| Early inflammatory markers in elicitation of allergic contact dermatitis | 17.2 | 0 | 1 |
| Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier | 17.2 | 0 | 1 |
| A coarse-grained molecular model for glycosaminoglycans: application to chondroitin, chondroitin sulfate, and hyaluronic acid. | 17.2 | 0 | 1 |
| Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid | 17.2 | 0 | 1 |
| Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci | 17.2 | 0 | 1 |
| Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection | 17.2 | 0 | 1 |
| Randomized, controlled trial evaluating a baby wash product on skin barrier function in healthy, term neonates | 17.2 | 0 | 1 |
| Population-Based Inorganic Mercury Biomonitoring and the Identification of Skin Care Products as a Source of Exposure in New York City | 17.2 | 0 | 1 |
| Lack of significant dermal penetration of titanium dioxide from sunscreen formulations containing nano- and submicron-size TiO2 particles | 17.2 | 0 | 1 |
| Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4 | 17.2 | 0 | 1 |
| Use of hyaluronic acid fillers for the treatment of the aging face | 17.2 | 0 | 1 |
| Tropic Skin Care | 17.2 | 0 | 1 |
| Identification of hyaluronic acid binding sites in the extracellular domain of CD44 | 17.2 | 0 | 1 |
| Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight | 17.2 | 0 | 1 |
| THE HYDROLYSIS OF HYALURONIC ACID BY BACTERIAL ENZYMES | 17.2 | 0 | 1 |
| Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis | 17.2 | 0 | 1 |
| Fate of ultrafine (UFTiO2) or fine titanium dioxide (FTiO2) following intratracheal instillation in rats | 17.2 | 0 | 1 |
| Fertility testing and ICSI sperm selection by hyaluronic acid binding: clinical and genetic aspects | 17.2 | 0 | 1 |
| Reflectance confocal microscopy may differentiate acute allergic and irritant contact dermatitis in vivo | 17.2 | 0 | 1 |
| Your results may vary: exploring the sensitivity of titanium dioxide risk estimates to different modeling assumptions | 17.2 | 0 | 1 |
| Molecular mechanism of skin irritation after acute exposure to m-xylene in rats and guinea pigs | 17.2 | 0 | 1 |
| Role of apoptosis induction in development of lung injury from high burdens of titanium dioxide | 17.2 | 0 | 1 |
| Automated spray can aerosol exposure system developed for inhalation studies involving products containing titanium dioxide nanoparticles | 17.2 | 0 | 1 |
| Exposure to titanium dioxide (TiO2) nanoparticles up-regulates neurotrophin expression in rodent airways | 17.2 | 0 | 1 |
| Intracellular hyaluronic acid binding protein | 17.2 | 0 | 1 |
| Two cases of occupational allergic contact dermatitis from a cycloaliphatic epoxy resin in a neat oil: case report | 17.2 | 0 | 1 |
| Titanium dioxide particle-induced goblet cell hyperplasia: association with mast cells and IL-13 | 17.2 | 0 | 1 |
| Impact on the quality of life of lymphoedema patients following introduction of a hygiene and skin care regimen in a Guyanese community endemic for lymphatic filariasis: A preliminary clinical intervention study | 17.2 | 0 | 1 |
| Cumulus expansion, nuclear maturation and connexin 43, cyclooxygenase-2 and FSH receptor mRNA expression in equine cumulus-oocyte complexes cultured in vitro in the presence of FSH and precursors for hyaluronic acid synthesis | 17.2 | 0 | 1 |
| Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis | 17.2 | 0 | 1 |
| Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action | 17.2 | 0 | 1 |
| Titanium dioxide: environmental white knight? | 17.2 | 0 | 1 |
| Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus | 17.2 | 0 | 1 |
| Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis | 17.2 | 0 | 1 |
| Evidence that ultrafine titanium dioxide induces micronuclei and apoptosis in Syrian hamster embryo fibroblasts | 17.2 | 0 | 1 |
| Pulmonary response to intratracheal instillation of fine or ultrafine carbon black or titanium dioxide: role of surface area | 17.2 | 0 | 1 |
| Health hazard evaluation report: HETA-2007-0261-3122, evaluation of contact dermatitis among ink ribbon manufacturing employees - New York | 17.2 | 0 | 1 |
| Engineered titanium dioxide nanowire toxicity in vitro and in vivo | 17.2 | 0 | 1 |
| Titanium dioxide (TiO2) | 17.2 | 0 | 1 |
| Comparison of glove contact allergen content and clinical patch test | 17.2 | 0 | 1 |
| Inhalation of ultrafine titanium dioxide augments particle-dependent microvascular dysfunction | 17.2 | 0 | 1 |
| Local lymph node assay as a quantitative risk assessment tool to model biologic skin response of allergic contact dermatitis in the mouse | 17.2 | 0 | 1 |
| Development of a small inhalation system for rodent exposure to fine and ultrafine titanium dioxide aerosols | 17.2 | 0 | 1 |
| A quantitative risk assessment in workers using rodent dose-response data of fine and ultrafine titanium dioxide | 17.2 | 0 | 1 |
| Development of new QSAR approaches in occupational contact dermatitis | 17.2 | 0 | 1 |
| Prediction of molecular mechanism of skin irritation after acute exposure to sodium lauryl sulfate | 17.2 | 0 | 1 |
| Winter season, frequent hand washing, and irritant patch test reactions to detergents are associated with hand dermatitis in health care workers | 17.2 | 0 | 1 |
| Skin absorption of inorganic lead (PbO) and the effect of skin cleansers | 17.2 | 0 | 1 |
| Pulmonary toxicity associated with nondispersed titanium dioxide nanorods | 17.2 | 0 | 1 |
| QSAR models of allergic contact dermatitis | 17.2 | 0 | 1 |
| Health hazard evaluation report: HETA-2006-0155-3072, evaluation of contact dermatitis among machinists at an automotive parts manufacturer, Dana Corporation, Bristol, Virginia | 17.2 | 0 | 1 |
| Cleanser-induced effects on skin barrier function | 17.2 | 0 | 1 |
| Effect of engineered titanium dioxide nanoparticle shape on toxicity in vivo | 17.2 | 0 | 1 |
| A structure-activity relationship (SAR) model for esters that cause human skin irritation | 17.2 | 0 | 1 |
| Titanium dioxide nanoparticles induce JB6 cell apoptosis through activation of the caspase-8/Bid pathway | 17.2 | 0 | 1 |
| Workshop on irritant contact dermatitis | 17.2 | 0 | 1 |
| Physicochemical properties and membranolytic activities of the titanium dioxide polymorphs compared with those of quartz | 17.2 | 0 | 1 |
| The effect of restraint on the development of allergic contact dermatitis is dependent upon the timing of the restraint | 17.2 | 0 | 1 |
| Comparative inhalation hazards of titanium dioxide, synthetic and natural graphite | 17.2 | 0 | 1 |
| The effect of aluminium citrate on electrokinetic potential on the surface of quartz and titanium dioxide particles | 17.2 | 0 | 1 |
| Experimental studies in rats on the effects of asbestos inhalation coupled with the inhalation of titanium dioxide | 17.2 | 0 | 1 |
| A study of allergic contact dermatitis caused by chrysanthemums -- characterization of allergens by skin tests on growers and sensitized guinea pigs | 17.2 | 0 | 1 |
| Restraint stress differentially affects cytokine production and ear swelling in allergic contact dermatitis (ACD) and irritant contact dermatitis (ICD) | 17.2 | 0 | 1 |
| Contact dermatitis in a plant that produces polyvinyl chloride compound | 17.2 | 0 | 1 |
| Allergic Contact Dermatitis From Ultraviolet Cured Inks | 17.2 | 0 | 1 |
| The role of antioxidants in skin immune reactions: the use of flow cytometry to determine alterations in Ia-positive epidermal cells in allergic contact dermatitis | 17.2 | 0 | 1 |
| Notes from the field: respiratory symptoms and skin irritation among hospital workers using a new disinfection product - Pennsylvania, 2015 | 17.2 | 0 | 1 |
| Contact dermatitis from use or misuse of soaps, detergents, and cleansers in the workplace | 17.2 | 0 | 1 |
| The epidemiology of occupational contact-dermatitis | 17.2 | 0 | 1 |
| Production of titanium dioxide pigment from perovskite concentrates, acid sulfation method | 17.2 | 0 | 1 |
| Selective recovery of arsenic from aqueous solutions with hydrated titanium dioxide | 17.2 | 0 | 1 |
| NIOSH Analytical Method, Titanium Dioxide, S385, (Set O) | 17.2 | 0 | 1 |
| Dressings and topical agents containing hyaluronic acid for chronic wound healing | 17.2 | 0 | 1 |
| Utility of the Atopy Patch Test in the Diagnosis of Allergic Rhinitis | 17.2 | 0 | 1 |
| Recent Updates in Neuroprotective and Neuroregenerative Potential of Centella asiatica | 17.2 | 0 | 1 |
| Genetic basis for hyper production of hyaluronic acid in natural and engineered microorganisms | 17.2 | 0 | 1 |
| Unraveling the neurotoxicity of titanium dioxide nanoparticles: focusing on molecular mechanisms | 17.2 | 0 | 1 |
| Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies | 17.2 | 0 | 1 |
| Clinical evidence in the treatment of rotator cuff tears with hyaluronic acid | 17.2 | 0 | 1 |
| Hyaluronic acid and tendon lesions | 17.2 | 0 | 1 |
| Systemic contact dermatitis | 17.2 | 0 | 1 |
| Possible Immune Regulation of Natural Killer T Cells in a Murine Model of Metal Ion-Induced Allergic Contact Dermatitis | 17.2 | 0 | 1 |
| Delayed-type Necrosis after Soft-tissue Augmentation with Hyaluronic Acid | 17.2 | 0 | 1 |
| The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review | 17.2 | 0 | 1 |
| Microspectroscopic Confocal Raman and Macroscopic Biophysical Measurements in the in vivo Assessment of the Skin Barrier: Perspective for Dermatology and Cosmetic Sciences | 17.2 | 0 | 1 |
| Glans Penis Augmentation Using Hyaluronic Acid Gel as an Injectable Filler | 17.2 | 0 | 1 |
| Nanomaterials in consumer products: a challenging analytical problem | 17.2 | 0 | 1 |
| Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis? | 17.2 | 0 | 1 |
| Skin care: Historical and contemporary views | 17.2 | 0 | 1 |
| Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis | 17.2 | 0 | 1 |
| Assessment of clinical practice guideline methodology for the treatment of knee osteoarthritis with intra-articular hyaluronic acid | 17.2 | 0 | 1 |
| Systematic Review for Effectiveness of Hyaluronic Acid in the Treatment of Severe Degenerative Joint Disease (DJD) of the Knee | 17.2 | 0 | 1 |
| State-of-the-Art management of knee osteoarthritis | 17.2 | 0 | 1 |
| Diagnostic dilemma: the enigma of an oral burning sensation | 17.2 | 0 | 1 |
| Coacervate delivery systems for proteins and small molecule drugs | 17.2 | 0 | 1 |
| Managing knee ostheoarthritis: efficacy of hyaluronic acid injections | 17.2 | 0 | 1 |
| Hyaluronic Acid and Wound Healing | 17.2 | 0 | 1 |
| Hyaluronic acid hydrogels for vocal fold wound healing | 17.2 | 0 | 1 |
| The effects of intravesical therapy with hyaluronic acid for painful bladder syndrome: Preliminary Chinese experience and systematic review | 17.2 | 0 | 1 |
| The role of skin care as an integral component in the management of acne vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and product selection | 17.2 | 0 | 1 |
| Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis | 17.2 | 0 | 1 |
| U.K. standards of care for occupational contact dermatitis and occupational contact urticaria | 17.2 | 0 | 1 |
| Drug Reaction, Skin Care, Skin Loss | 17.2 | 0 | 1 |
| Hyaluronic Acid: from biochemical characteristics to its clinical translation in assessment of liver fibrosis | 17.2 | 0 | 1 |
| Incorporation of a barrier protection cream in the management of chronic hand dermatitis: focus on data supporting an established hand protectant formulation and modifications designed to assist in barrier repair | 17.2 | 0 | 1 |
| Epidermal Permeability Barrier Defects and Barrier Repair Therapy in Atopic Dermatitis | 17.2 | 0 | 1 |
| hyaluronan | 17.2 | 0 | 1 |
| beta-D-GlcpA-(1->3)-beta-D-GlcpNAc-(1->4)-beta-D-GlcpA-(1->3)-D-GlcpNAc | 17.2 | 0 | 1 |
| Cationic liposome–hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens | 17.2 | 0 | 1 |
| Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation | 17.2 | 0 | 1 |
| Perpendicular Strut Injection of Hyaluronic Acid Filler for Deep Wrinkles | 17.2 | 0 | 1 |
| The Electrical Conductivity of Titanium Dioxide | 17.2 | 0 | 1 |
| Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 A resolution | 17.2 | 0 | 1 |
| Hyaluronic acid: molecular conformations and interactions in two sodium salts | 17.2 | 0 | 1 |
| Hyaluronic acid: Structure of a fully extended 3-fold helical sodium salt and comparison with the less extended 4-fold helical forms | 17.2 | 0 | 1 |
| Mechanisms of chemical-induced innate immunity in allergic contact dermatitis | 17.2 | 0 | 1 |
| Hyaluronic acid: The role of divalent cations in conformation and packing | 17.2 | 0 | 1 |
| Effects of titanium dioxide nanoparticles on human keratinocytes | 17.2 | 0 | 1 |
| JRCNM01000a | 17.2 | 0 | 1 |
| Novel concept of iSALT (inducible skin-associated lymphoid tissue) in the elicitation of allergic contact dermatitis | 17.2 | 0 | 1 |
| Skin barrier in rosacea | 17.2 | 0 | 1 |
| Hyaluronic acid fillers with cohesive polydensified matrix for soft-tissue augmentation and rejuvenation: a literature review | 17.2 | 0 | 1 |
| Developing food allergy: a potential immunologic pathway linking skin barrier to gut | 17.2 | 0 | 1 |
| Volumetric techniques: three-dimensional midface modeling | 17.2 | 0 | 1 |
| Hyaluronic Acid: Perspectives in Upper Aero-Digestive Tract. A Systematic Review | 17.2 | 0 | 1 |
| Effectiveness of hyaluronic acid administration in treating adhesive capsulitis of the shoulder: a systematic review of randomized controlled trials | 17.2 | 0 | 1 |
| Targeting transporters: Promoting blood–brain barrier repair in response to oxidative stress injury | 17.2 | 0 | 1 |
| A Facile Method for Separating and Enriching Nano and Submicron Particles from Titanium Dioxide Found in Food and Pharmaceutical Products | 17.2 | 0 | 1 |
| CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration | 17.2 | 0 | 1 |
| Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells | 17.2 | 0 | 1 |
| Neonatal skin care: the scientific basis for practice | 17.2 | 0 | 1 |
| Allergic contact dermatitis from triethanolamine in a sunscreen | 17.2 | 0 | 1 |
| Skin irritation and dryness associated with two hand-hygiene regimens: soap-and-water hand washing versus hand antisepsis with an alcoholic hand gel | 17.2 | 0 | 1 |
| Cosmetics and skin care products. A historical perspective | 17.2 | 0 | 1 |
| Tetrazepam allergy once more detected by patch test | 17.2 | 0 | 1 |
| Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors | 17.2 | 0 | 1 |
| Effect of Centella asiatica Linn on physical and chemical factors induced gastric ulceration and secretion in rats | 17.2 | 0 | 1 |
| Non-steroidal and steroidal anti-inflammatory drugs vary in their modulation of dendritic cell function in the elicitation phase of allergic contact dermatitis | 17.2 | 0 | 1 |
| Skin care management: educational aspects | 17.2 | 0 | 1 |
| Emblica cascading antioxidant: a novel natural skin care ingredient | 17.2 | 0 | 1 |
| Role of vitamins in skin care | 17.2 | 0 | 1 |
| The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes | 17.2 | 0 | 1 |
| Allergic contact dermatitis | 17.2 | 0 | 1 |
| Tetrazepam drug sensitivity -- usefulness of the patch test | 17.2 | 0 | 1 |
| The skin barrier as an innate immune element | 17.2 | 0 | 1 |
| Evidence-Based Skin Care Management in Radiation Therapy: Clinical Update | 17.2 | 0 | 1 |
| Short-term effects of alcohol-based disinfectant and detergent on skin irritation | 17.2 | 0 | 1 |
| Induction of hyaluronic acid synthase 2 (HAS2) in human vascular smooth muscle cells by vasodilatory prostaglandins | 17.2 | 0 | 1 |
| Filaggrin in the frontline: role in skin barrier function and disease | 17.2 | 0 | 1 |
| Allergic contact dermatitis to cocamidopropyl betaine in shampoo | 17.2 | 0 | 1 |
| Dynamic cytoplasmic anchoring of the transcription factor Bach1 by intracellular hyaluronic acid binding protein IHABP | 17.2 | 0 | 1 |
| Occupational airborne contact dermatitis from sporadic exposure to tetrazepam during machine maintenance | 17.2 | 0 | 1 |
| A novel method to inject hyaluronic acid: the Fern Pattern Technique | 17.2 | 0 | 1 |
| Contact dermatitis allergy to common ivy (Hedera helix L.) | 17.2 | 0 | 1 |
| Allergic contact dermatitis resulting from sensitivity to citrus peel, geraniol, and citral | 17.2 | 0 | 1 |
| Skin care practices for newborns and infants: review of the clinical evidence for best practices | 17.2 | 0 | 1 |
| Safety of blocking vascular adhesion protein-1 in patients with contact dermatitis | 17.2 | 0 | 1 |
| Contact dermatitis due to lanoconazole, cetyl alcohol and diethyl sebacate in lanoconazole cream | 17.2 | 0 | 1 |
| Evidence-based skin care management in radiation therapy | 17.2 | 0 | 1 |
| Histoplasmin skin sensitivity in Nova Scotia | 17.2 | 0 | 1 |
| The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin | 17.2 | 0 | 1 |
| The benefits of implementing a new skin care protocol in nursing homes | 17.2 | 0 | 1 |
| The validity of skin care protocols followed by women with breast cancer receiving external radiation | 17.2 | 0 | 1 |
| Allergy to cocamidopropyl betaine may be due to amidoamine: a patch test and product use test study | 17.2 | 0 | 1 |
| Allergic contact dermatitis following aromatherapy with valiya narayana thailam--an ayurvedic oil presenting as exfoliative dermatitis | 17.2 | 0 | 1 |
| Evidence-Based Skin Care: A Systematic Literature Review and the Development of a Basic Skin Care Algorithm | 17.2 | 0 | 1 |
| Skin Care | 17.2 | 0 | 1 |
| Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillers | 17.2 | 0 | 1 |
| In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen | 17.2 | 0 | 1 |
| Safety and efficacy of clocortolone pivalate 0.1 percent cream in the treatment of atopic dermatitis, contact dermatitis, and seborrheic dermatitis | 17.2 | 0 | 1 |
| The effectiveness of jewelweed, Impatiens capensis, the related cultivar I. balsamina and the component, lawsone in preventing post poison ivy exposure contact dermatitis | 17.2 | 0 | 1 |
| Allergic contact dermatitis to ethoxyquin in a farmer handling chicken feeds | 17.2 | 0 | 1 |
| Allergic contact dermatitis to cocamidopropylbetaine in hair shampoo | 17.2 | 0 | 1 |
| The concept of the acid mantle of the skin: its relevance for the choice of skin cleansers | 17.2 | 0 | 1 |
| An evaluation of the effect of an alpha hydroxy acid-blend skin cream in the cosmetic improvement of symptoms of moderate to severe xerosis, epidermolytic hyperkeratosis, and ichthyosis | 17.2 | 0 | 1 |
| The Infant Skin Barrier: Can We Preserve, Protect, and Enhance the Barrier? | 17.2 | 0 | 1 |
| Studies on the role of leukotrienes in murine allergic and irritant contact dermatitis | 17.2 | 0 | 1 |
| Assignment of cDNA Encoding Hyaluronic Acid-Binding Protein 1 to Human Chromosome 17p12–p13 | 17.2 | 0 | 1 |
| Purification, partial characterization of rat kidney hyaluronic acid binding protein and its localization on the cell surface | 17.2 | 0 | 1 |
| Contact dermatitis from Grevillea 'Robyn Gordon' | 17.2 | 0 | 1 |
| Severe contact dermatitis caused by mephenesin | 17.2 | 0 | 1 |
| Innovations in natural ingredients and their use in skin care | 17.2 | 0 | 1 |
| Allergic contact dermatitis caused by mushrooms. A case report and literature review | 17.2 | 0 | 1 |
| Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study | 17.2 | 0 | 1 |
| A survey of skin problems and skin care regimens in the elderly | 17.2 | 0 | 1 |
| A case of contact dermatitis due to impurities of cetyl alcohol | 17.2 | 0 | 1 |
| Articular Cartilage Regeneration With Autologous Peripheral Blood Progenitor Cells and Hyaluronic Acid After Arthroscopic Subchondral Drilling: A Report of 5 Cases With Histology | 17.2 | 0 | 1 |
| Allergic contact dermatitis to ethylenediamine. A continuing problem | 17.2 | 0 | 1 |
| Tetrazepam allergy detected by patch test | 17.2 | 0 | 1 |
| Allergic contact dermatitis releases soluble factors that stimulate melanogenesis through activation of protein kinase C-related signal-transduction pathway | 17.2 | 0 | 1 |
| A murine in vitro model of allergic contact dermatitis to sesquiterpene alpha-methylene-gamma-butyrolactones | 17.2 | 0 | 1 |
| The leukocyte migration test in nickel contact dermatitis | 17.2 | 0 | 1 |
| Lymphocyte transformation induced by nickel sulphate: an in vitro study of subjects with and without a positive nickel patch test | 17.2 | 0 | 1 |
| Recurrent angioneurotic oedema and contact dermatitis due to penicillin | 17.2 | 0 | 1 |
| Allergic contact dermatitis to isopropylaminodiphenylamine (IPPD) | 17.2 | 0 | 1 |
| A New Animal Model for Contact Dermatitis: The Hairless Guinea Pig | 17.2 | 0 | 1 |
| Contact allergies to topical corticosteroids: 10 cases of contact dermatitis | 17.2 | 0 | 1 |
| Stinging sensation from elhoxyethyl – methoxy cinnamate | 17.2 | 0 | 1 |
| Brilliant Lake Red R as a cause of pigmented contact dermatitis | 17.2 | 0 | 1 |
| Synthesis of and allergic contact dermatitis to bicyclo-[2,2,1]-heptyl-α-methylene-γ-butyrolactones derived from norbornene and camphene | 17.2 | 0 | 1 |
| Hexachlorophene emulsions and antiseptic skin care of newborn infants | 17.2 | 0 | 1 |
| Chemical change involved in the oxidative reductive depolymerization of hyaluronic acid | 17.2 | 0 | 1 |
| Propofol causes a burning sensation on injection | 17.2 | 0 | 1 |
| Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis | 17.2 | 0 | 1 |
| Allergic contact dermatitis to underwear elastic. Chemically transformed by laundry bleach | 17.2 | 0 | 1 |
| Allergic contact dermatitis from dental composite resins due to aromatic epoxy acrylates and aliphatic acrylates | 17.2 | 0 | 1 |
| Allergic contact dermatitis from 1,2-dichloropropane | 17.2 | 0 | 1 |
| Allergic contact dermatitis from topical corticosteroids | 17.2 | 0 | 1 |
| Allergic Contact Dermatitis to Low Molecular Weight Allergens in the Chicken | 17.2 | 0 | 1 |
| Nickel-induced proliferation of both memory and naive T cells in patch test-negative individuals | 17.2 | 0 | 1 |
| Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients | 17.2 | 0 | 1 |
| A comparative study of the expression of cytotoxic proteins in allergic contact dermatitis and psoriasis: spongiotic skin lesions in allergic contact dermatitis are highly infiltrated by T cells expressing perforin and granzyme B | 17.2 | 0 | 1 |
| Contact dermatitis in students practicing sports: incidence of rubber sensitisation | 17.2 | 0 | 1 |
| Quantification of allergic and irritant patch test reactions using ImageJ | 17.2 | 0 | 1 |
| Allergic contact dermatitis from 3-iodo-2-propynyl-butylcarbamate in a cosmetic cream | 17.2 | 0 | 1 |
| Serotonin in human allergic contact dermatitis. An immunohistochemical and high-performance liquid chromatographic study | 17.2 | 0 | 1 |
| Titanium Dioxide Exposure Induces Acute Eosinophilic Lung Inflammation in Rabbits | 17.2 | 0 | 1 |
| Sunscreens with Titanium Dioxide (TiO2) Nano-Particles: A Societal Experiment | 17.2 | 0 | 1 |
| The Effect of Nano-Titanium Dioxide on Limb Bud Development of NMRI Mouse Embryo In Vivo | 17.2 | 0 | 1 |
| The prevalence and possible causes of contact dermatitis in farmworkers | 17.2 | 0 | 1 |
| Titanium Dioxide Nanoparticles: Grassian et al. Respond | 17.2 | 0 | 1 |
| Molecular mechanism of DNA damage induced by titanium dioxide nanoparticles in toll-like receptor 3 or 4 expressing human hepatocarcinoma cell lines | 17.2 | 0 | 1 |
| Titanium dioxide nanoparticle impact and translocation through ex vivo, in vivo and in vitro gut epithelia | 17.2 | 0 | 1 |
| Carbon black and titanium dioxide nanoparticles induce distinct molecular mechanisms of toxicity | 17.2 | 0 | 1 |
| Titanium Dioxide Nanoparticles Trigger Loss of Function and Perturbation of Mitochondrial Dynamics in Primary Hepatocytes | 17.2 | 0 | 1 |
| Mucin secretion induced by titanium dioxide nanoparticles | 17.2 | 0 | 1 |
| Gene expression profiling of immune-competent human cells exposed to engineered zinc oxide or titanium dioxide nanoparticles | 17.2 | 0 | 1 |
| Toxic effects of the interaction of titanium dioxide nanoparticles with chemicals or physical factors | 17.2 | 0 | 1 |
| Intratracheally instilled titanium dioxide nanoparticles translocate to heart and liver and activate complement cascade in the heart of C57BL/6 mice | 17.2 | 0 | 1 |
| The effect of blood protein adsorption on cellular uptake of anatase TiO2 nanoparticles | 17.2 | 0 | 1 |
| A review on potential neurotoxicity of titanium dioxide nanoparticles | 17.2 | 0 | 1 |
| Critical review of public health regulations of titanium dioxide, a human food additive | 17.2 | 0 | 1 |
| Assessment of agglomeration, co-sedimentation and trophic transfer of titanium dioxide nanoparticles in a laboratory-scale predator-prey model system | 17.2 | 0 | 1 |
| Titanium Dioxide Nanoparticle Penetration into the Skin and Effects on HaCaT Cells | 17.2 | 0 | 1 |
| Exposure to titanium dioxide and other metallic oxide nanoparticles induces cytotoxicity on human neural cells and fibroblasts | 17.2 | 0 | 1 |
| Titanium dioxide in our everyday life; is it safe? | 17.2 | 0 | 1 |
| Tissue biodistribution of intravenously administrated titanium dioxide nanoparticles revealed blood-brain barrier clearance and brain inflammation in rat | 17.2 | 0 | 1 |
| Review of titanium dioxide nanoparticle phototoxicity: Developing a phototoxicity ratio to correct the endpoint values of toxicity tests | 17.2 | 0 | 1 |
| Lung exposure of titanium dioxide nanoparticles induces innate immune activation and long-lasting lymphocyte response in the Dark Agouti rat | 17.2 | 0 | 1 |
| Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue | 17.2 | 0 | 1 |
| Genotoxicity Studies of Titanium Dioxide Nanoparticles (TiO2NPs) in the Brain of Mice | 17.2 | 0 | 1 |
| RETRACTED ARTICLE: Mechanisms of nanosized titanium dioxide-induced testicular oxidative stress and apoptosis in male mice | 17.2 | 0 | 1 |
| Titanium dioxide nanoparticles stimulate sea urchin immune cell phagocytic activity involving TLR/p38 MAPK-mediated signalling pathway | 17.2 | 0 | 1 |
| The Ginkgo biloba Extract Reverses the Renal Effects of Titanium Dioxide Nanoparticles in Adult Male Rats | 17.2 | 0 | 1 |
| Shape-Related Toxicity of Titanium Dioxide Nanofibres | 17.2 | 0 | 1 |
| Dose-dependent autophagic effect of titanium dioxide nanoparticles in human HaCaT cells at non-cytotoxic levels | 17.2 | 0 | 1 |
| Biological Response to Nano-Scale Titanium Dioxide (TiO2): Role of Particle Dose, Shape, and Retention | 17.2 | 0 | 1 |
| Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps | 17.2 | 0 | 1 |
| Trojan-Like Internalization of Anatase Titanium Dioxide Nanoparticles by Human Osteoblast Cells | 17.2 | 0 | 1 |
| Intratracheally administered titanium dioxide or carbon black nanoparticles do not aggravate elastase-induced pulmonary emphysema in rats | 17.2 | 0 | 1 |
| Nasal and Pulmonary Toxicity of Titanium Dioxide Nanoparticles in Rats | 17.2 | 0 | 1 |
| Halometasone monohydrate (0.05%) in occupational contact dermatitis | 17.2 | 0 | 1 |
| Few Associations Found between Mold and Other Allergen Concentrations in the Home versus Skin Sensitivity from Children with Asthma after Hurricane Katrina in the Head-Off Environmental Asthma in Louisiana Study | 17.2 | 0 | 1 |
| Titanium Dioxide Particle Type and Concentration Influence the Inflammatory Response in Caco-2 Cells | 17.2 | 0 | 1 |
| Mitochondrial dysfunction and loss of glutamate uptake in primary astrocytes exposed to titanium dioxide nanoparticles | 17.2 | 0 | 1 |
| Role of Surface Area, Primary Particle Size, and Crystal Phase on Titanium Dioxide Nanoparticle Dispersion Properties | 17.2 | 0 | 1 |
| Contrasting macrophage activation by fine and ultrafine titanium dioxide particles is associated with different uptake mechanisms | 17.2 | 0 | 1 |
| Titanium Dioxide Nanoparticles are not Cytotoxic or Clastogenic in Human Skin Cells | 17.2 | 0 | 1 |
| Downregulation of B-cell lymphoma/leukemia-2 by overexpressed microRNA 34a enhanced titanium dioxide nanoparticle-induced autophagy in BEAS-2B cells | 17.2 | 0 | 1 |
| Effects of the physicochemical properties of titanium dioxide nanoparticles, commonly used as sun protection agents, on microvascular endothelial cells | 17.2 | 0 | 1 |
| Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation | 17.2 | 0 | 1 |
| Inhalation exposure study of titanium dioxide nanoparticles with a primary particle size of 2 to 5 nm | 17.2 | 0 | 1 |
| Workplace Exposure to Titanium Dioxide Nanopowder Released from a Bag Filter System | 17.2 | 0 | 1 |
| Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administration | 17.2 | 0 | 1 |
| Re-evaluation of pulmonary titanium dioxide nanoparticle distribution using the "relative deposition index": Evidence for clearance through microvasculature | 17.2 | 0 | 1 |
| Toxicogenomics analysis of mouse lung responses following exposure to titanium dioxide nanomaterials reveal their disease potential at high doses | 17.2 | 0 | 1 |
| Effects of prenatal exposure to surface-coated nanosized titanium dioxide (UV-Titan). A study in mice | 17.2 | 0 | 1 |
| Titanium Dioxide Nanoparticles Induce Endoplasmic Reticulum Stress-Mediated Autophagic Cell Death via Mitochondria-Associated Endoplasmic Reticulum Membrane Disruption in Normal Lung Cells | 17.2 | 0 | 1 |
| Three human cell types respond to multi-walled carbon nanotubes and titanium dioxide nanobelts with cell-specific transcriptomic and proteomic expression patterns | 17.2 | 0 | 1 |
| Titanium dioxide induces apoptotic cell death through reactive oxygen species-mediated Fas upregulation and Bax activation | 17.2 | 0 | 1 |
| Titanium dioxide nanoparticles induce the expression of early and late receptors for adhesion molecules on monocytes | 17.2 | 0 | 1 |
| Titanium Dioxide Nanoparticles Increase Superoxide Anion Production by Acting on NADPH Oxidase | 17.2 | 0 | 1 |
| Skin barrier homeostasis in atopic dermatitis: feedback regulation of kallikrein activity | 17.2 | 0 | 1 |
| Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans | 17.2 | 0 | 1 |
| Vehicle Exhaust Gas Clearance by Low Temperature Plasma-Driven Nano-Titanium Dioxide Film Prepared by Radiofrequency Magnetron Sputtering | 17.2 | 0 | 1 |
| Harlequin ichthyosis model mouse reveals alveolar collapse and severe fetal skin barrier defects | 17.2 | 0 | 1 |
| Temporally controlled targeted somatic mutagenesis in embryonic surface ectoderm and fetal epidermal keratinocytes unveils two distinct developmental functions of BRG1 in limb morphogenesis and skin barrier formation | 17.2 | 0 | 1 |
| Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice | 17.2 | 0 | 1 |
| Acute toxicity of intravenously administered titanium dioxide nanoparticles in mice | 17.2 | 0 | 1 |
| CD44 Binding to Hyaluronic Acid Is Redox Regulated by a Labile Disulfide Bond in the Hyaluronic Acid Binding Site | 17.2 | 0 | 1 |
| Sustained Effect of Hyaluronic Acid in Subcutaneous Administration to the Cochlear Spiral Ganglion | 17.2 | 0 | 1 |
| Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model | 17.2 | 0 | 1 |
| Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome | 17.2 | 0 | 1 |
| Superresolution and Fluorescence Dynamics Evidence Reveal That Intact Liposomes Do Not Cross the Human Skin Barrier | 17.2 | 0 | 1 |
| Hyaluronan binding protein 2 | 17.2 | 0 | 1 |
| Hyaluronan synthase 2 | 17.2 | 0 | 1 |
| Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44 | 17.2 | 0 | 1 |
| An in vitro study of the effect of size and timing of administration of titanium dioxide particles on antigen presenting activity of alveolar macrophages and peripheral blood monocytes | 17.2 | 0 | 1 |
| Assessment of skin irritation and molecular responses in rat skin exposed to nonane, dodecane and tetradecane | 17.2 | 0 | 1 |
| Effect of methyl substitution of benzene on the percutaneous absorption and skin irritation in hairless rats | 17.2 | 0 | 1 |
| The effect of hyaluronic acid size and concentration on branching morphogenesis and tubule differentiation in developing kidney culture systems: potential applications to engineering of renal tissues | 17.2 | 0 | 1 |
| Changes in brain biogenic amines and haem biosynthesis and their response to combined administration of succimers and Centella asiatica in lead poisoned rats | 17.2 | 0 | 1 |
| Lipopenia and skin barrier abnormalities in DGAT2-deficient mice | 17.2 | 0 | 1 |
| Co-axial heterostructures integrating palladium/titanium dioxide with carbon nanotubes for efficient electrocatalytic hydrogen evolution | 17.2 | 0 | 1 |
| GPHR-dependent functions of the Golgi apparatus are essential for the formation of lamellar granules and the skin barrier | 17.2 | 0 | 1 |
| Excessive reactive oxygen species induces apoptosis in fibroblasts: role of mitochondrially accumulated hyaluronic acid binding protein 1 (HABP1/p32/gC1qR) | 17.2 | 0 | 1 |
| Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein | 17.2 | 0 | 1 |
| Increased retinoic acid levels through ablation of Cyp26b1 determine the processes of embryonic skin barrier formation and peridermal development | 17.2 | 0 | 1 |
| Cardiovascular Effects of Pulmonary Exposure to Titanium Dioxide Nanoparticles in ApoE Knockout Mice | 17.2 | 0 | 1 |
| Use of titanium dioxide nanoparticles biosynthesized by Bacillus mycoides in quantum dot sensitized solar cells | 17.2 | 0 | 1 |
| Nanostructured Graphene-Titanium Dioxide Composites Synthesized by a Single-Step Aerosol Process for Photoreduction of Carbon Dioxide. | 17.2 | 0 | 1 |
| Comparative study of normal and sensitive skin aerobic bacterial populations | 17.2 | 0 | 1 |
| Titanium Dioxide Nanofibers and Microparticles Containing Nickel Nanoparticles | 17.2 | 0 | 1 |
| Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation | 17.2 | 0 | 1 |
| Improved in vitro angiogenic behavior on anodized titanium dioxide nanotubes | 17.2 | 0 | 1 |
| Diclofenac-Induced Allergic Contact Dermatitis: A Series of Four Patients | 17.2 | 0 | 1 |
| In vitro and In vivo Antioxidant, Anti-hyperlipidemic Properties and Chemical Characterization of Centella asiatica (L.) Extract | 17.2 | 0 | 1 |
| Physicochemical characterization of titanium dioxide pigments using various techniques for size determination and asymmetric flow field flow fractionation hyphenated with inductively coupled plasma mass spectrometry | 17.2 | 0 | 1 |
| Induction of Cancer Cell Death by Hyaluronic Acid-Mediated Uptake of Cytochrome C | 17.2 | 0 | 1 |
| Hyaluronic acid-modified multifunctional Q-graphene for targeted killing of drug-resistant lung cancer cells | 17.2 | 0 | 1 |
| A Survey of Skin Problems and Skin Care Regimens in the Elderly | 17.2 | 0 | 1 |
| The surface science of titanium dioxide | 17.2 | 0 | 1 |
| Bolden | 17.2 | 0 | 1 |
| Seeking Clearer Recommendations for Hand Hygiene in Communities Facing Ebola: A Randomized Trial Investigating the Impact of Six Handwashing Methods on Skin Irritation and Dermatitis | 17.2 | 0 | 1 |
| Antibacterial Properties of Visible-Light-Responsive Carbon-Containing Titanium Dioxide Photocatalytic Nanoparticles against Anthrax | 17.2 | 0 | 1 |
| Targeting and Photodynamic Killing of Cancer Cell by Nitrogen-Doped Titanium Dioxide Coupled with Folic Acid | 17.2 | 0 | 1 |
| The antibacterial effects of silver, titanium dioxide and silica dioxide nanoparticles compared to the dental disinfectant chlorhexidine onStreptococcus mutansusing a suite of bioassays | 17.2 | 0 | 1 |
| Comparison of Cellular Uptake and Inflammatory Response via Toll-Like Receptor 4 to Lipopolysaccharide and Titanium Dioxide Nanoparticles | 17.2 | 0 | 1 |
| CONTACT DERMATITIS OF THE FACE DUE TO MATCHES | 17.2 | 0 | 1 |
| The Validity and Practicality of Sun-Reactive Skin Types I Through VI | 17.2 | 0 | 1 |
| Formation of Cold-Sprayed Ceramic Titanium Dioxide Layers on Metal Surfaces | 17.2 | 0 | 1 |
| Hyaluronan binding protein 4 | 17.2 | 0 | 1 |
| Lymphatic vessel endothelial hyaluronan receptor 1 | 17.2 | 0 | 1 |
| Hyaluronan-mediated motility receptor | 17.2 | 0 | 1 |
| Contact hypersensitivity and allergic contact dermatitis among school children and teenagers with eczema | 17.2 | 0 | 1 |
| LOC563048 | 17.2 | 0 | 1 |
| Barrier cream formulations to reduce skin permeation of nicotine as a preventive measure for green tobacco sickness | 17.2 | 0 | 1 |
| Efficacy study of a nicotine barrier cream | 17.2 | 0 | 1 |
| Allergic contact dermatitis resulting from sensitivity to citrus peel, geraniol, and citral | 17.2 | 0 | 1 |
| Complications of Injectable Fillers, Part 2: Vascular Complications | 17.2 | 0 | 1 |
| Reactive skin decontamination lotion (RSDL) for the decontamination of chemical warfare agent (CWA) dermal exposure | 17.2 | 0 | 1 |
| Introduction of community-based skin-to-skin care in rural Uttar Pradesh, India | 17.2 | 0 | 1 |
| Use of Intra-Articular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice | 17.2 | 0 | 1 |
| Hair-care practices in African American women: potential for allergic contact dermatitis | 17.2 | 0 | 1 |
| Development of linear and threshold no significant risk levels for inhalation exposure to titanium dioxide using systematic review and mode of action considerations | 17.2 | 0 | 1 |
| Michigan Center for Skin Care Research | 17.2 | 0 | 1 |
| New York Laser and Skin Care | 17.2 | 0 | 1 |
| Skin Care and Laser Physicians of Beverly Hills | 17.2 | 0 | 1 |
| Institut Esthederm | 17.2 | 0 | 1 |
| Hyaluronan Research Institute | 17.2 | 0 | 1 |
| Gold Skin Care Center | 17.2 | 0 | 1 |
| Associated Skin Care Specialists | 17.2 | 0 | 1 |
| Perineal skin care for the incontinent patient | 17.2 | 0 | 1 |
| Tender mercies: providing skin care for an incontinent patient | 17.2 | 0 | 1 |
| Protecting perineal skin integrity. Incontinent patients present unique challenges to successful skin care management. | 17.2 | 0 | 1 |
| E45 cream | 17.2 | 0 | 1 |
| Study of the effect of mixing approach on cross-linking efficiency of hyaluronic acid-based hydrogel cross-linked with 1,4-butanediol diglycidyl ether | 17.2 | 0 | 1 |
| Development and characterization of microemulsions containing hyaluronic acid | 17.2 | 0 | 1 |
| Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer | 17.2 | 0 | 1 |
| Bioactivity of immobilized hyaluronic acid derivatives regarding protein adsorption and cell adhesion. | 17.2 | 0 | 1 |
| Determination of titanium dioxide supplements in different matrices using two methods involving photometer and inductively coupled plasma optical emission spectrometer measurements | 17.2 | 0 | 1 |
| Incorporating skin care into a facial plastic surgery practice | 17.2 | 0 | 1 |
| Adsorption of Acid Orange 7 on the surface of titanium dioxide | 17.2 | 0 | 1 |
| Optical clearing of skin enhanced with hyaluronic acid for increased contrast of optoacoustic imaging. | 17.2 | 0 | 1 |
| Trehalose and hyaluronic acid coordinately stabilized freeze-dried pancreatic kininogenase. | 17.2 | 0 | 1 |
| Nanotubes-Embedded Indocyanine Green-Hyaluronic Acid Nanoparticles for Photoacoustic-Imaging-Guided Phototherapy | 17.2 | 0 | 1 |
| Evaluation of Hyaluronic Acid Dilutions at Different Concentrations Using a Quartz Crystal Resonator (QCR) for the Potential Diagnosis of Arthritic Diseases | 17.2 | 0 | 1 |
| Complex coacervates of hyaluronic acid and lysozyme: effect on protein structure and physical stability | 17.2 | 0 | 1 |
| Clinically tested toothpaste and other fairy tales - a critical approach to reading pharmaceutical advertisements and professional papers. | 17.2 | 0 | 1 |
| Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C. | 17.2 | 0 | 1 |
| Titanium dioxide nanoparticles enhance production of superoxide anion and alter the antioxidant system in human osteoblast cells | 17.2 | 0 | 1 |
| Sorption of Eu(III) onto titanium dioxide: measurements and modeling | 17.2 | 0 | 1 |
| Phenol photocatalytic degradation by advanced oxidation process under ultraviolet radiation using titanium dioxide. | 17.2 | 0 | 1 |
| Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells | 17.2 | 0 | 1 |
| Skin Barrier Defects in Atopic Dermatitis | 17.2 | 0 | 1 |
| Black Hydroxylated Titanium Dioxide Prepared via Ultrasonication with Enhanced Photocatalytic Activity | 17.2 | 0 | 1 |
| Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors | 17.2 | 0 | 1 |
| Controllably local gene delivery mediated by polyelectrolyte multilayer films assembled from gene-loaded nanopolymersomes and hyaluronic acid | 17.2 | 0 | 1 |
| Titanium dioxide nanoparticles activate the ATM-Chk2 DNA damage response in human dermal fibroblasts | 17.2 | 0 | 1 |
| Do you know where your fillers go? An ultrastructural investigation of the lips | 17.2 | 0 | 1 |
| Factors correlating with acoustic radiation force impulse elastography in chronic hepatitis C | 17.2 | 0 | 1 |
| In vitro cultivation of canine multipotent mesenchymal stromal cells on collagen membranes treated with hyaluronic acid for cell therapy and tissue regeneration. | 17.2 | 0 | 1 |
| Quality of the voice after injection of hyaluronic acid into the vocal fold | 17.2 | 0 | 1 |
| Preliminary histopathological study of intra-articular injection of a novel highly cross-linked hyaluronic acid in a rabbit model of knee osteoarthritis | 17.2 | 0 | 1 |
| Recent Trends in the Surgical Management of Primary Vesicoureteral Reflux in the Era of Dextranomer/Hyaluronic Acid | 17.2 | 0 | 1 |
| First Report of Septoria centellae Associated with Leaf Spot of Centella asiatica in Korea | 17.2 | 0 | 1 |
| Self-assembled monolayers and titanium dioxide: From surface patterning to potential applications | 17.2 | 0 | 1 |
| The design of in vitro liver sinusoid mimics using chitosan-hyaluronic acid polyelectrolyte multilayers | 17.2 | 0 | 1 |
| Pharmacological review on Centella asiatica: A potential herbal cure-all | 17.2 | 0 | 1 |
| Promotion of osteoblast proliferation on complex coacervation-based hyaluronic acid - recombinant mussel adhesive protein coatings on titanium | 17.2 | 0 | 1 |
| Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation | 17.2 | 0 | 1 |
| Allergic contact dermatitis to colophony in a violoncellist | 17.2 | 0 | 1 |
| The alarmin Mrp8/14 as regulator of the adaptive immune response during allergic contact dermatitis | 17.2 | 0 | 1 |
| Allergic contact dermatitis in a violinist. The role of abietic acid--a sensitizer in rosin (colophony)--as the causative agent. | 17.2 | 0 | 1 |
| Allergic contact dermatitis on a violinist's neck from para‐phenylenediamine in a chin rest stain | 17.2 | 0 | 1 |
| Allergic contact dermatitis from colophony and Compositae in a violinist | 17.2 | 0 | 1 |
| Allergic contact dermatitis from colophonium, turpentine and ebony in a violinist presenting as fiddler's neck | 17.2 | 0 | 1 |
| Allergic contact dermatitis to purpleheart and padauk wood (Pterocarpus dalbergiodes). | 17.2 | 0 | 1 |
| Occlusive irritant dermatitis: when is "allergic" contact dermatitis not allergic? | 17.2 | 0 | 1 |
| Allergic contact dermatitis of the lips in a recorder player caused by African blackwood | 17.2 | 0 | 1 |
| Surface treatment of flexor tendon autografts with carbodiimide-derivatized hyaluronic Acid. An in vivo canine model | 17.2 | 0 | 1 |
| Fiddler's neck: Chin rest-associated irritant contact dermatitis and allergic contact dermatitis in a violin player | 17.2 | 0 | 1 |
| Applicability of in vitro tests for skin irritation and corrosion to regulatory classification schemes: Substantiating test strategies with data from routine studies | 17.2 | 0 | 1 |
| Effect of vehicles and elicitation concentration in contact dermatitis testing II. Statistical analysis of data | 17.2 | 0 | 1 |
| Occupational contact dermatitis in hairdressers/cosmetologists: retrospective analysis of north american contact dermatitis group data, 1994 to 2010. | 17.2 | 0 | 1 |
| Significance-prevalence index number: a reinterpretation and enhancement of data from the North American contact dermatitis group | 17.2 | 0 | 1 |